| 1 |
Oxaliplatin FDA Label
|
| 2 |
ClinicalTrials.gov (NCT05294172) KL-A167 Injection Combined With Cisplatin and Gemcitabine vs Placebo Combined With Cisplatin and Gemcitabine in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma: A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Clinical Trial. U.S.National Institutes of Health.
|
| 3 |
Overexpression of PIN1 Enhances Cancer Growth and Aggressiveness with Cyclin D1 Induction in EBV-Associated Nasopharyngeal Carcinoma.PLoS One. 2016 Jun 3;11(6):e0156833.
|
| 4 |
Nasopharyngeal carcinoma: Current treatment options and future directions. J Nasopharyng Carcinoma, 2014, 1(16): e16.
|
| 5 |
Promoting tumorigenesis in nasopharyngeal carcinoma, NEDD8 serves as a potential theranostic target.Cell Death Dis. 2017 Jun 1;8(6):e2834.
|
| 6 |
ClinicalTrials.gov (NCT00953420) Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes (CADEN). U.S. National Institutes of Health.
|
| 7 |
Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| 8 |
ClinicalTrials.gov (NCT00834093) A Phase II Study of Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma. U.S. National Institutes of Health.
|
| 9 |
UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3/-catenin pathway.Oncotarget. 2016 Mar 22;7(12):15161-72.
|
| 10 |
Therapeutic efficacy of seliciclib in combination with ionizing radiation for human nasopharyngeal carcinoma.Clin Cancer Res. 2009 Jun 1;15(11):3716-24.
|
| 11 |
ClinicalTrials.gov (NCT02980315) A New EBV Related Technologies of T Cells in Treating Malignant Tumors and Clinical Application
|
| 12 |
XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.Theranostics. 2018 Feb 5;8(6):1494-1510.
|
| 13 |
Sphingosine kinase 1 is a potential therapeutic target for nasopharyngeal carcinoma.Oncotarget. 2016 Dec 6;7(49):80586-80598.
|
| 14 |
CA patent application no. 876139, Nanotherapeutics for drug targeting.
|
| 15 |
PDZ binding kinase (PBK) is a theranostic target for nasopharyngeal carcinoma: driving tumor growth via ROS signaling and correlating with patient survival.Oncotarget. 2016 May 3;7(18):26604-16.
|
| 16 |
Recurrent FGFR3-TACC3 fusion gene in nasopharyngeal carcinoma.Cancer Biol Ther. 2014;15(12):1613-21.
|
| 17 |
Polo-like kinase inhibitor Ro5203280 has potent antitumor activity in nasopharyngeal carcinoma.Mol Cancer Ther. 2013 Aug;12(8):1393-401.
|
| 18 |
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma.Cancer Res. 2017 Dec 1;77(23):6614-6626.
|
| 19 |
Overexpression of acylglycerol kinase is associated with poorer prognosis and lymph node metastasis in nasopharyngeal carcinoma.Tumour Biol. 2016 Mar;37(3):3349-57. doi: 10.1007/s13277-015-4148-x. Epub 2015 Oct 7.
|
| 20 |
AGR2 diagnostic value in nasopharyngeal carcinoma prognosis.Clin Chim Acta. 2018 Sep;484:323-327. doi: 10.1016/j.cca.2017.12.023. Epub 2017 Dec 18.
|
| 21 |
EGFR-PKM2 signaling promotes the metastatic potential of nasopharyngeal carcinoma through induction of FOSL1 and ANTXR2.Carcinogenesis. 2020 Jul 10;41(6):723-733. doi: 10.1093/carcin/bgz180.
|
| 22 |
APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.FASEB J. 2019 Nov;33(11):11959-11972. doi: 10.1096/fj.201802416RR. Epub 2019 Aug 13.
|
| 23 |
Bioinformatics analysis identifies hub genes and pathways in nasopharyngeal carcinoma.Oncol Lett. 2019 Oct;18(4):3637-3645. doi: 10.3892/ol.2019.10707. Epub 2019 Aug 2.
|
| 24 |
BST2 confers cisplatin resistance via NF-B signaling in nasopharyngeal cancer.Cell Death Dis. 2017 Jun 15;8(6):e2874. doi: 10.1038/cddis.2017.271.
|
| 25 |
RNAi-mediated knockdown of CAIX enhances the radiosensitivity of nasopharyngeal carcinoma cell line, CNE-2.Onco Targets Ther. 2017 Sep 25;10:4701-4709. doi: 10.2147/OTT.S144756. eCollection 2017.
|
| 26 |
EVI1 promotes epithelial-to-mesenchymal transition, cancer stem cell features and chemo-/radioresistance in nasopharyngeal carcinoma.J Exp Clin Cancer Res. 2019 Feb 15;38(1):82. doi: 10.1186/s13046-019-1077-3.
|
| 27 |
Inhibition of Anaphase-Promoting Complex by Silence APC/C(Cdh1) to Enhance Radiosensitivity of Nasopharyngeal Carcinoma Cells.J Cell Biochem. 2017 Oct;118(10):3150-3157. doi: 10.1002/jcb.25854. Epub 2017 Jun 20.
|
| 28 |
Cadherin 6 is activated by Epstein-Barr virus LMP1 to mediate EMT and metastasis as an interplay node of multiple pathways in nasopharyngeal carcinoma.Oncogenesis. 2017 Dec 22;6(12):402. doi: 10.1038/s41389-017-0005-7.
|
| 29 |
Clinical evaluation of vascular normalization induced by recombinant human endostatin in nasopharyngeal carcinoma via dynamic contrast-enhanced ultrasonography.Onco Targets Ther. 2018 Nov 8;11:7909-7917. doi: 10.2147/OTT.S181842. eCollection 2018.
|
| 30 |
A deep survival analysis method based on ranking.Artif Intell Med. 2019 Jul;98:1-9. doi: 10.1016/j.artmed.2019.06.001. Epub 2019 Jun 6.
|
| 31 |
Increased Expression of Cullin 3 in Nasopharyngeal Carcinoma and Knockdown Inhibits Proliferation and Invasion.Oncol Res. 2018 Jan 19;26(1):111-122. doi: 10.3727/096504017X14924753593574. Epub 2017 Apr 18.
|
| 32 |
Role of SDF-1/CXCR4 signaling pathway in clinicopathological features and prognosis of patients with nasopharyngeal carcinoma.Biosci Rep. 2017 Jul 12;37(4):BSR20170144. doi: 10.1042/BSR20170144. Print 2017 Aug 31.
|
| 33 |
CYP2E1 polymorphisms and nasopharyngeal carcinoma risk: a meta-analysis.Eur Arch Otorhinolaryngol. 2017 Jan;274(1):253-259. doi: 10.1007/s00405-016-4236-6. Epub 2016 Aug 4.
|
| 34 |
Epstein-Barr virus noncoding RNAs from the extracellular vesicles of nasopharyngeal carcinoma (NPC) cells promote angiogenesis via TLR3/RIG-I-mediated VCAM-1 expression.Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1201-1213. doi: 10.1016/j.bbadis.2019.01.015. Epub 2019 Jan 16.
|
| 35 |
DEPDC1 is required for cell cycle progression and motility in nasopharyngeal carcinoma.Oncotarget. 2017 Jun 29;8(38):63605-63619. doi: 10.18632/oncotarget.18868. eCollection 2017 Sep 8.
|
| 36 |
Bile acids at neutral and acidic pH induce apoptosis and gene cleavages in nasopharyngeal epithelial cells: implications in chromosome rearrangement.BMC Cancer. 2018 Apr 12;18(1):409. doi: 10.1186/s12885-018-4327-4.
|
| 37 |
Differential diagnosis of nasopharyngeal carcinoma and nasopharyngeal lymphoma based on DCE-MRI and RESOLVE-DWI.Eur Radiol. 2020 Jan;30(1):110-118. doi: 10.1007/s00330-019-06343-0. Epub 2019 Aug 1.
|
| 38 |
c-myc gene inactivation during induction of nasopharyngeal carcinoma cells with retinoic acid.Chin Med J (Engl). 2000 Sep;113(9):823-6.
|
| 39 |
PPAR- Ligand Inhibits Nasopharyngeal Carcinoma Cell Proliferation and Metastasis by Regulating E2F2.PPAR Res. 2019 Aug 1;2019:8679271. doi: 10.1155/2019/8679271. eCollection 2019.
|
| 40 |
Elevated EGFL6 modulates cell metastasis and growth via AKT pathway in nasopharyngeal carcinoma.Cancer Med. 2018 Dec;7(12):6281-6289. doi: 10.1002/cam4.1883. Epub 2018 Nov 15.
|
| 41 |
Ribavirin sensitizes nasopharyngeal carcinoma to 5-fluorouracil through suppressing 5-fluorouracil-induced ERK-dependent-eIF4E activation.Biochem Biophys Res Commun. 2019 Jun 11;513(4):862-868. doi: 10.1016/j.bbrc.2019.04.053. Epub 2019 Apr 16.
|
| 42 |
Garcinone C exerts antitumor activity by modulating the expression of ATR/Stat3/4EBP1 in nasopharyngeal carcinoma cells.Oncol Rep. 2018 Mar;39(3):1485-1493. doi: 10.3892/or.2018.6218. Epub 2018 Jan 16.
|
| 43 |
Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy.BMC Cancer. 2016 Aug 22;16(1):669. doi: 10.1186/s12885-016-2714-2.
|
| 44 |
The efficacy of cisplatin on nasopharyngeal carcinoma cells may be increased via the downregulation of fibroblast growth factor receptor 2.Int J Mol Med. 2019 Jul;44(1):57-66. doi: 10.3892/ijmm.2019.4193. Epub 2019 May 10.
|
| 45 |
Prognostic impact of immunohistopathologic features in definitive radiation therapy for nasopharyngeal cancer patients.J Radiat Res. 2020 Jan 23;61(1):161-168. doi: 10.1093/jrr/rrz071.
|
| 46 |
Simultaneous Inhibition of EGFR and HER2 via Afatinib Augments the Radiosensitivity of Nasopharyngeal Carcinoma Cells.J Cancer. 2019 May 12;10(9):2063-2073. doi: 10.7150/jca.29327. eCollection 2019.
|
| 47 |
The genomic landscape of nasopharyngeal carcinoma.Nat Genet. 2014 Aug;46(8):866-71.
|
| 48 |
Blockage of SSRP1/Ets-1/Pim-3 signalling enhances chemosensitivity of nasopharyngeal carcinoma to docetaxel in vitro.Biomed Pharmacother. 2016 Oct;83:1022-1031. doi: 10.1016/j.biopha.2016.08.022. Epub 2016 Aug 12.
|
| 49 |
Inhibition of Ezrin suppresses cell migration and invasion in human nasopharyngeal carcinoma.Oncol Lett. 2019 Jul;18(1):553-560. doi: 10.3892/ol.2019.10370. Epub 2019 May 17.
|
| 50 |
miR-543 promoted the cell proliferation and invasion of nasopharyngeal carcinoma by targeting the JAM-A.Hum Cell. 2019 Oct;32(4):477-486. doi: 10.1007/s13577-019-00274-0. Epub 2019 Aug 19.
|
| 51 |
Identification of genomic alterations in nasopharyngeal carcinoma and nasopharyngeal carcinoma-derived Epstein-Barr virus by whole-genome sequencing.Carcinogenesis. 2018 Dec 31;39(12):1517-1528. doi: 10.1093/carcin/bgy108.
|
| 52 |
Long noncoding RNA AFAP1-AS1 acts as a competing endogenous RNA of miR-423-5p to facilitate nasopharyngeal carcinoma metastasis through regulating the Rho/Rac pathway.J Exp Clin Cancer Res. 2018 Oct 16;37(1):253. doi: 10.1186/s13046-018-0918-9.
|
| 53 |
The long noncoding RNA FOXCUT promotes proliferation and migration by targeting FOXC1 in nasopharyngeal carcinoma.Tumour Biol. 2017 Jun;39(6):1010428317706054. doi: 10.1177/1010428317706054.
|
| 54 |
microRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells.BMC Cancer. 2019 Jan 24;19(1):104. doi: 10.1186/s12885-018-5225-5.
|
| 55 |
MiR-145 inhibits metastasis by targeting fascin actin-bundling protein 1 in nasopharyngeal carcinoma.PLoS One. 2015 Mar 27;10(3):e0122228. doi: 10.1371/journal.pone.0122228. eCollection 2015.
|
| 56 |
MicroRNA-425 is downregulated in nasopharyngeal carcinoma and regulates tumor cell viability and invasion by targeting hepatoma-derived growth factor.Oncol Lett. 2018 May;15(5):6345-6351. doi: 10.3892/ol.2018.8128. Epub 2018 Feb 27.
|
| 57 |
Characterization of a novel allelic variant in HLA-B*40 lineage, HLA-B*40:298:02, by cloning and sequencing.Int J Immunogenet. 2018 Jun;45(3):143-145. doi: 10.1111/iji.12372. Epub 2018 Apr 20.
|
| 58 |
LncRNA SOX2-OT regulates proliferation and metastasis of nasopharyngeal carcinoma cells through miR-146b-5p/HNRNPA2B1 pathway.J Cell Biochem. 2019 Oct;120(10):16575-16588. doi: 10.1002/jcb.28917. Epub 2019 May 17.
|
| 59 |
Increased expression of heat shock protein (HSP) 10 and HSP70 correlates with poor prognosis of nasopharyngeal carcinoma.Cancer Manag Res. 2019 Sep 6;11:8219-8227. doi: 10.2147/CMAR.S218427. eCollection 2019.
|
| 60 |
Interferon beta increases NK cell cytotoxicity against tumor cells in patients with nasopharyngeal carcinoma via tumor necrosis factor apoptosis-inducing ligand.Cancer Immunol Immunother. 2019 Aug;68(8):1317-1329. doi: 10.1007/s00262-019-02368-y. Epub 2019 Jul 16.
|
| 61 |
Epstein-Barr Virus BART Long Non-coding RNAs Function as Epigenetic Modulators in Nasopharyngeal Carcinoma.Front Oncol. 2019 Oct 22;9:1120. doi: 10.3389/fonc.2019.01120. eCollection 2019.
|
| 62 |
Dendritic cell subpopulations in nasopharyngeal cancer.Oncol Lett. 2019 Feb;17(2):2557-2561. doi: 10.3892/ol.2018.9835. Epub 2018 Dec 14.
|
| 63 |
High expression of IMPDH2 is associated with aggressive features and poor prognosis of primary nasopharyngeal carcinoma.Sci Rep. 2017 Apr 7;7(1):745. doi: 10.1038/s41598-017-00887-1.
|
| 64 |
Degradation of cofilin is regulated by Cbl, AIP4 and Syk resulting in increased migration of LMP2A positive nasopharyngeal carcinoma cells.Sci Rep. 2017 Aug 21;7(1):9012. doi: 10.1038/s41598-017-09540-3.
|
| 65 |
miR-29c regulates resistance to paclitaxel in nasopharyngeal cancer by targeting ITGB1.Exp Cell Res. 2019 May 1;378(1):1-10. doi: 10.1016/j.yexcr.2019.02.012. Epub 2019 Feb 16.
|
| 66 |
JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression.BMC Cancer. 2017 Jul 11;17(1):477. doi: 10.1186/s12885-017-3473-4.
|
| 67 |
Keratin 6A gene silencing suppresses cell invasion and metastasis of nasopharyngeal carcinoma via the catenin cascade.Mol Med Rep. 2019 May;19(5):3477-3484. doi: 10.3892/mmr.2019.10055. Epub 2019 Mar 18.
|
| 68 |
Hydroxypropyl-beta and -gamma cyclodextrins rescue cholesterol accumulation in Niemann-Pick C1 mutant cell via lysosome-associated membrane protein 1.Cell Death Dis. 2018 Oct 3;9(10):1019. doi: 10.1038/s41419-018-1056-1.
|
| 69 |
Quantitative proteome analysis identifies MAP2K6 as potential regulator of LIFR-induced radioresistance in nasopharyngeal carcinoma cells.Biochem Biophys Res Commun. 2018 Oct 20;505(1):274-281. doi: 10.1016/j.bbrc.2018.09.020. Epub 2018 Sep 21.
|
| 70 |
MiR-194 regulates nasopharyngeal carcinoma progression by modulating MAP3K3 expression.FEBS Open Bio. 2018 Nov 26;9(1):43-52. doi: 10.1002/2211-5463.12545. eCollection 2019 Jan.
|
| 71 |
Pre-treatment with angiotensin-(1-7) inhibits tumor growth via autophagy by downregulating PI3K/Akt/mTOR signaling in human nasopharyngeal carcinoma xenografts.J Mol Med (Berl). 2018 Dec;96(12):1407-1418. doi: 10.1007/s00109-018-1704-z. Epub 2018 Oct 29.
|
| 72 |
Design, synthesis and biological evaluation of 4-aniline-thieno[2,3-d]pyrimidine derivatives as MNK1 inhibitors against renal cell carcinoma and nasopharyngeal carcinoma.Bioorg Med Chem. 2019 Jun 1;27(11):2268-2279. doi: 10.1016/j.bmc.2019.04.022. Epub 2019 Apr 17.
|
| 73 |
MTA1 promotes viability and motility in nasopharyngeal carcinoma by modulating IQGAP1 expression.J Cell Biochem. 2018 May;119(5):3864-3872. doi: 10.1002/jcb.26494. Epub 2018 Jan 22.
|
| 74 |
Metadherin contributes to epithelial-mesenchymal transition and paclitaxel resistance induced by acidic extracellular pH in nasopharyngeal carcinoma.Oncol Lett. 2018 Mar;15(3):3858-3863. doi: 10.3892/ol.2018.7760. Epub 2018 Jan 10.
|
| 75 |
Oxidative stress-induced chromosome breaks within the ABL gene: a model for chromosome rearrangement in nasopharyngeal carcinoma.Hum Genomics. 2018 Jun 18;12(1):29. doi: 10.1186/s40246-018-0160-8.
|
| 76 |
microRNA-613 exerts anti-angiogenic effect on nasopharyngeal carcinoma cells through inactivating the AKT signaling pathway by down-regulating FN1.Biosci Rep. 2019 Jul 10;39(7):BSR20182196. doi: 10.1042/BSR20182196. Print 2019 Jul 31.
|
| 77 |
Identification and validation nucleolin as a target of curcumol in nasopharyngeal carcinoma cells.J Proteomics. 2018 Jun 30;182:1-11. doi: 10.1016/j.jprot.2018.04.025. Epub 2018 Apr 22.
|
| 78 |
NEDD4 is involved in acquisition of epithelial-mesenchymal transition in cisplatin-resistant nasopharyngeal carcinoma cells.Cell Cycle. 2017 May 3;16(9):869-878. doi: 10.1080/15384101.2017.1308617. Epub 2017 Apr 5.
|
| 79 |
The NOR1/OSCP1 proteins in cancer: from epigenetic silencing to functional characterization of a novel tumor suppressor.J Cancer. 2017 Feb 25;8(4):626-635. doi: 10.7150/jca.17579. eCollection 2017.
|
| 80 |
MicroRNA-372 enhances radiosensitivity while inhibiting cell invasion and metastasis in nasopharyngeal carcinoma through activating the PBK-dependent p53 signaling pathway.Cancer Med. 2019 Feb;8(2):712-728. doi: 10.1002/cam4.1924. Epub 2019 Jan 18.
|
| 81 |
Chibby suppresses aerobic glycolysis and proliferation of nasopharyngeal carcinoma via the Wnt/-catenin-Lin28/let7-PDK1 cascade.J Exp Clin Cancer Res. 2018 May 15;37(1):104. doi: 10.1186/s13046-018-0769-4.
|
| 82 |
PFKFB3 promotes proliferation, migration and angiogenesis in nasopharyngeal carcinoma.J Cancer. 2017 Oct 23;8(18):3887-3896. doi: 10.7150/jca.19112. eCollection 2017.
|
| 83 |
Translational genomics of nasopharyngeal cancer.Semin Cancer Biol. 2020 Apr;61:84-100. doi: 10.1016/j.semcancer.2019.09.006. Epub 2019 Sep 12.
|
| 84 |
Insufficient PINX1 expression stimulates telomerase activation by direct inhibition of EBV LMP1-NF-B axis during nasopharyngeal carcinoma development.Biochem Biophys Res Commun. 2019 Jun 18;514(1):127-133. doi: 10.1016/j.bbrc.2019.04.104. Epub 2019 Apr 23.
|
| 85 |
Acetylsalicylic acid inhibits the growth of melanoma tumors via SOX2-dependent-PAF-R-independent signaling pathway.Oncotarget. 2017 Jul 25;8(30):49959-49972. doi: 10.18632/oncotarget.18326.
|
| 86 |
RIPK4 promoted the tumorigenicity of nasopharyngeal carcinoma cells.Biomed Pharmacother. 2018 Dec;108:1-6. doi: 10.1016/j.biopha.2018.08.147. Epub 2018 Sep 10.
|
| 87 |
5T4-specific chimeric antigen receptor modification promotes the immune efficacy of cytokine-induced killer cells against nasopharyngeal carcinoma stem cell-like cells.Sci Rep. 2017 Jul 7;7(1):4859. doi: 10.1038/s41598-017-04756-9.
|
| 88 |
LncRNA NEAT1/let-7a-5p axis regulates the cisplatin resistance in nasopharyngeal carcinoma by targeting Rsf-1 and modulating the Ras-MAPK pathway.Cancer Biol Ther. 2018 Jun 3;19(6):534-542. doi: 10.1080/15384047.2018.1450119. Epub 2018 Apr 9.
|
| 89 |
Impact of RTN4 gene polymorphism and its plasma level on susceptibility to nasopharyngeal carcinoma: A case-control study.Medicine (Baltimore). 2019 Nov;98(47):e17831. doi: 10.1097/MD.0000000000017831.
|
| 90 |
Overexpression of Nogo receptor 3 (NgR3) correlates with poor prognosis and contributes to the migration of epithelial cells of nasopharyngeal carcinoma patients.J Mol Med (Berl). 2018 Apr;96(3-4):265-279. doi: 10.1007/s00109-017-1618-1. Epub 2018 Jan 11.
|
| 91 |
Knockdown of serpin peptidase inhibitor clade C member1 inhibits the growth of nasopharyngeal carcinoma cells.Mol Med Rep. 2019 May;19(5):3658-3666. doi: 10.3892/mmr.2019.10021. Epub 2019 Mar 14.
|
| 92 |
Serum proteomics identify potential biomarkers for nasopharyngeal carcinoma sensitivity to radiotherapy.Biosci Rep. 2019 May 14;39(5):BSR20190027. doi: 10.1042/BSR20190027. Print 2019 May 31.
|
| 93 |
Correction: Deficiency of pigment epithelium-derived factor in nasopharyngeal carcinoma cells triggers the epithelial-mesenchymal transition and metastasis.Cell Death Dis. 2018 Jul 16;9(8):784. doi: 10.1038/s41419-018-0829-x.
|
| 94 |
Expression and prognostic utility of SSX2IP in patients with nasopharyngeal carcinoma.APMIS. 2020 Apr;128(4):287-297. doi: 10.1111/apm.13023. Epub 2020 Jan 29.
|
| 95 |
Stanniocalcin 2 (STC2) expression promotes post-radiation survival, migration and invasion of nasopharyngeal carcinoma cells.Cancer Manag Res. 2019 Jul 11;11:6411-6424. doi: 10.2147/CMAR.S197607. eCollection 2019.
|
| 96 |
STYK1 promotes Warburg effect through PI3K/AKT signaling and predicts a poor prognosis in nasopharyngeal carcinoma.Tumour Biol. 2017 Jul;39(7):1010428317711644. doi: 10.1177/1010428317711644.
|
| 97 |
TNFAIP3 inhibits migration and invasion in nasopharyngeal carcinoma by suppressing epithelial mesenchymal transition.Neoplasma. 2017;64(3):389-394. doi: 10.4149/neo_2017_309.
|
| 98 |
TRIM24 siRNA induced cell apoptosis and reduced cell viability in human nasopharyngeal carcinoma cells.Mol Med Rep. 2018 Jul;18(1):369-376. doi: 10.3892/mmr.2018.8946. Epub 2018 May 2.
|
| 99 |
The lncRNA PVT1 regulates nasopharyngeal carcinoma cell proliferation via activating the KAT2A acetyltransferase and stabilizing HIF-1.Cell Death Differ. 2020 Feb;27(2):695-710. doi: 10.1038/s41418-019-0381-y. Epub 2019 Jul 18.
|
| 100 |
CDC42-interacting protein 4 promotes metastasis of nasopharyngeal carcinoma by mediating invadopodia formation and activating EGFR signaling.J Exp Clin Cancer Res. 2017 Jan 28;36(1):21. doi: 10.1186/s13046-016-0483-z.
|
| 101 |
Cancer-Specifically Re-Spliced TSG101 mRNA Promotes Invasion and Metastasis of Nasopharyngeal Carcinoma.Int J Mol Sci. 2019 Feb 12;20(3):773. doi: 10.3390/ijms20030773.
|
| 102 |
miR-663b promotes tumor cell proliferation, migration and invasion in nasopharyngeal carcinoma through targeting TUSC2.Exp Ther Med. 2017 Aug;14(2):1095-1103. doi: 10.3892/etm.2017.4608. Epub 2017 Jun 14.
|
| 103 |
Minicircle-oriP-miR-31 as a Novel EBNA1-Specific miRNA Therapy Approach for Nasopharyngeal Carcinoma.Hum Gene Ther. 2017 May;28(5):415-427. doi: 10.1089/hum.2016.136. Epub 2016 Dec 29.
|
| 104 |
The anti-tumor function of the IKK inhibitor PS1145 and high levels of p65 and KLF4 are associated with the drug resistance in nasopharyngeal carcinoma cells.Sci Rep. 2019 Aug 19;9(1):12064. doi: 10.1038/s41598-019-48590-7.
|
| 105 |
Identification of candidate genes of nasopharyngeal carcinoma by bioinformatical analysis.Arch Oral Biol. 2019 Oct;106:104478. doi: 10.1016/j.archoralbio.2019.07.003. Epub 2019 Jul 5.
|
| 106 |
EZH2-DNMT1-mediated epigenetic silencing of miR-142-3p promotes metastasis through targeting ZEB2 in nasopharyngeal carcinoma.Cell Death Differ. 2019 Jun;26(6):1089-1106. doi: 10.1038/s41418-018-0208-2. Epub 2018 Oct 23.
|
| 107 |
Identification of the zinc finger 216 (ZNF216) in human carcinoma cells: a potential regulator of EGFR activity.Oncotarget. 2016 Nov 15;7(46):74947-74965. doi: 10.18632/oncotarget.12509.
|
| 108 |
VE-822 mediated inhibition of ATR signaling sensitizes chondrosarcoma to cisplatin via reversion of the DNA damage response.Onco Targets Ther. 2019 Jul 30;12:6083-6092. doi: 10.2147/OTT.S211560. eCollection 2019.
|
| 109 |
BACE1-cleavage of Sez6 and Sez6L is elevated in Niemann-Pick type C disease mouse brains.PLoS One. 2018 Jul 6;13(7):e0200344. doi: 10.1371/journal.pone.0200344. eCollection 2018.
|
| 110 |
Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A.PLoS One. 2011 Apr 26;6(4):e19137. doi: 10.1371/journal.pone.0019137.
|
| 111 |
microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network.Carcinogenesis. 2010 Apr;31(4):559-66. doi: 10.1093/carcin/bgp335. Epub 2010 Jan 6.
|
| 112 |
The expression of BTG1 is downregulated in nasopharyngeal carcinoma and possibly associated with tumour metastasis.Mol Biol Rep. 2014 Sep;41(9):5979-88. doi: 10.1007/s11033-014-3475-0. Epub 2014 Jul 2.
|
| 113 |
RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma.Int J Cancer. 2004 May 10;109(6):839-47. doi: 10.1002/ijc.20079.
|
| 114 |
Characterization of CACNA2D3 as a putative tumor suppressor gene in the development and progression of nasopharyngeal carcinoma.Int J Cancer. 2013 Nov 15;133(10):2284-95. doi: 10.1002/ijc.28252. Epub 2013 Jul 13.
|
| 115 |
Plasma Macrophage Migration Inhibitory Factor and CCL3 as Potential Biomarkers for Distinguishing Patients with Nasopharyngeal Carcinoma from High-Risk Individuals Who Have Positive Epstein-Barr Virus Capsid Antigen-Specific IgA.Cancer Res Treat. 2019 Jan;51(1):378-390. doi: 10.4143/crt.2018.070. Epub 2018 May 29.
|
| 116 |
Sequencing of DC-SIGN promoter indicates an association between promoter variation and risk of nasopharyngeal carcinoma in cantonese.BMC Med Genet. 2010 Nov 11;11:161. doi: 10.1186/1471-2350-11-161.
|
| 117 |
Elevated expression of ICAM1 (CD54) and minimal expression of LFA3 (CD58) in Epstein-Barr-virus-positive nasopharyngeal carcinoma cells.Int J Cancer. 1992 Apr 1;50(6):863-7. doi: 10.1002/ijc.2910500605.
|
| 118 |
Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer.Int J Cancer. 2010 May 1;126(9):2036-48. doi: 10.1002/ijc.24880.
|
| 119 |
CDK3 expression and its clinical significance in human nasopharyngeal carcinoma.Mol Med Rep. 2014 Jun;9(6):2582-6. doi: 10.3892/mmr.2014.2095. Epub 2014 Mar 31.
|
| 120 |
Identification of genes related to nasopharyngeal carcinoma with the help of pathway-based networks.Acta Biochim Biophys Sin (Shanghai). 2006 Dec;38(12):900-10. doi: 10.1111/j.1745-7270.2006.00235.x.
|
| 121 |
Role of a genetic variant on the 15q25.1 lung cancer susceptibility locus in smoking-associated nasopharyngeal carcinoma.PLoS One. 2014 Oct 20;9(10):e109036. doi: 10.1371/journal.pone.0109036. eCollection 2014.
|
| 122 |
A survey of methylated candidate tumor suppressor genes in nasopharyngeal carcinoma.Int J Cancer. 2011 Mar 15;128(6):1393-403. doi: 10.1002/ijc.25443.
|
| 123 |
Complement receptor 1 expression in peripheral blood mononuclear cells and the association with clinicopathological features and prognosis of nasopharyngeal carcinoma.Asian Pac J Cancer Prev. 2012;13(12):6527-31. doi: 10.7314/apjcp.2012.13.12.6527.
|
| 124 |
Reexploring the possible roles of some genes associated with nasopharyngeal carcinoma using microarray-based detection.Acta Biochim Biophys Sin (Shanghai). 2005 Aug;37(8):541-6. doi: 10.1111/j.1745-7270.2005.00074.x.
|
| 125 |
Gene expression profiling of nasopharyngeal carcinoma reveals the abnormally regulated Wnt signaling pathway.Hum Pathol. 2007 Jan;38(1):120-33. doi: 10.1016/j.humpath.2006.06.023. Epub 2006 Sep 25.
|
| 126 |
Upregulation of discoidin domain receptor 2 in nasopharyngeal carcinoma.Head Neck. 2008 Apr;30(4):427-36. doi: 10.1002/hed.20724.
|
| 127 |
Meta-analysis of nasopharyngeal carcinoma microarray data explores mechanism of EBV-regulated neoplastic transformation.BMC Genomics. 2008 Jul 7;9:322. doi: 10.1186/1471-2164-9-322.
|
| 128 |
Identification of candidate molecular markers of nasopharyngeal carcinoma by tissue microarray and in situ hybridization.Med Oncol. 2011 Dec;28 Suppl 1:S341-8. doi: 10.1007/s12032-010-9727-5. Epub 2010 Nov 5.
|
| 129 |
CCAAT/enhancer binding protein in macrophages contributes to immunosuppression and inhibits phagocytosis in nasopharyngeal carcinoma.Sci Signal. 2013 Jul 16;6(284):ra59. doi: 10.1126/scisignal.2003648.
|
| 130 |
Expression of Epstein-Barr virus genes and of lymphocyte activation molecules in undifferentiated nasopharyngeal carcinomas.Am J Pathol. 1992 Apr;140(4):879-87.
|
| 131 |
miR-143 inhibits proliferation and metastasis of nasopharyngeal carcinoma cells via targeting FMNL1 based on clinical and radiologic findings.J Cell Biochem. 2019 Oct;120(10):16427-16434. doi: 10.1002/jcb.28709. Epub 2019 Apr 18.
|
| 132 |
GALC gene is downregulated by promoter hypermethylation in Epstein-Barr virus-associated nasopharyngeal carcinoma.Oncol Rep. 2015 Sep;34(3):1369-78. doi: 10.3892/or.2015.4134. Epub 2015 Jul 14.
|
| 133 |
Expression of GRIN2A in benign and malignant nasopharyngeal diseases and its clinical significance.Genet Mol Res. 2015 Dec 17;14(4):17289-95. doi: 10.4238/2015.December.16.29.
|
| 134 |
Heparanase is involved in the proliferation and invasion of nasopharyngeal carcinoma cells.Oncol Rep. 2013 May;29(5):1888-94. doi: 10.3892/or.2013.2325. Epub 2013 Mar 5.
|
| 135 |
Expression of LEF1 and TCF1 (TCF7) proteins associates with clinical progression of nasopharyngeal carcinoma.J Clin Pathol. 2019 Jun;72(6):425-430. doi: 10.1136/jclinpath-2019-205698. Epub 2019 Mar 27.
|
| 136 |
LASP1 promotes nasopharyngeal carcinoma progression through negatively regulation of the tumor suppressor PTEN.Cell Death Dis. 2018 Mar 12;9(3):393. doi: 10.1038/s41419-018-0443-y.
|
| 137 |
The regulation and interaction of colon cancer-associated transcript-1 and miR7-5p contribute to the inhibition of SP1 expression by solamargine in human nasopharyngeal carcinoma cells.Phytother Res. 2020 Jan;34(1):201-213. doi: 10.1002/ptr.6555. Epub 2019 Dec 10.
|
| 138 |
Downregulation of p57kip promotes cell invasion via LIMK/cofilin pathway in human nasopharyngeal carcinoma cells.J Cell Biochem. 2011 Nov;112(11):3459-68. doi: 10.1002/jcb.23277.
|
| 139 |
Down-regulation of LPA receptor 5 contributes to aberrant LPA signalling in EBV-associated nasopharyngeal carcinoma.J Pathol. 2015 Feb;235(3):456-65. doi: 10.1002/path.4460. Epub 2014 Dec 18.
|
| 140 |
Identification of a novel 12p13.3 amplicon in nasopharyngeal carcinoma.J Pathol. 2010 Jan;220(1):97-107. doi: 10.1002/path.2609.
|
| 141 |
The oncogenic protein kinase Tpl-2/Cot contributes to Epstein-Barr virus-encoded latent infection membrane protein 1-induced NF-kappaB signaling downstream of TRAF2.J Virol. 2002 May;76(9):4567-79. doi: 10.1128/jvi.76.9.4567-4579.2002.
|
| 142 |
The effect of functional MAPKAPK2 copy number variation CNV-30450 on elevating nasopharyngeal carcinoma risk is modulated by EBV infection.Carcinogenesis. 2014 Jan;35(1):46-52. doi: 10.1093/carcin/bgt314. Epub 2013 Sep 20.
|
| 143 |
Identification of genes with allelic imbalance on 6p associated with nasopharyngeal carcinoma in southern Chinese.PLoS One. 2011 Jan 20;6(1):e14562. doi: 10.1371/journal.pone.0014562.
|
| 144 |
Chromosomal abnormalities associated with neck nodal metastasis in nasopharyngeal carcinoma.Tumour Biol. 2005 Nov-Dec;26(6):306-12. doi: 10.1159/000089289. Epub 2005 Oct 26.
|
| 145 |
Sequence analysis of Epstein-Barr virus EBNA-2 gene coding amino acid 148-487 in nasopharyngeal and gastric carcinomas.Virol J. 2012 Feb 21;9:49. doi: 10.1186/1743-422X-9-49.
|
| 146 |
Monocyte-derived factors including PLA2G7 induced by macrophage-nasopharyngeal carcinoma cell interaction promote tumor cell invasiveness.Oncotarget. 2016 Aug 23;7(34):55473-55490. doi: 10.18632/oncotarget.10980.
|
| 147 |
PPAR/ Agonist GW501516 Inhibits Tumorigenesis and Promotes Apoptosis of the Undifferentiated Nasopharyngeal Carcinoma C666-1 Cells by Regulating miR-206.Oncol Res. 2019 Aug 8;27(8):923-933. doi: 10.3727/096504019X15518706875814. Epub 2019 Apr 8.
|
| 148 |
Ovatodiolide suppresses nasopharyngeal cancer by targeting stem cell-like population, inducing apoptosis, inhibiting EMT and dysregulating JAK/STAT signaling pathway.Phytomedicine. 2019 Mar 15;56:269-278. doi: 10.1016/j.phymed.2018.05.007. Epub 2018 May 8.
|
| 149 |
The DLC-1 -29A/T polymorphism is not associated with nasopharyngeal carcinoma risk in Chinese population.Genet Test. 2008 Sep;12(3):345-9. doi: 10.1089/gte.2007.0121.
|
| 150 |
Mitogen- and stress-activated Kinase 1 mediates Epstein-Barr virus latent membrane protein 1-promoted cell transformation in nasopharyngeal carcinoma through its induction of Fra-1 and c-Jun genes.BMC Cancer. 2015 May 10;15:390. doi: 10.1186/s12885-015-1398-3.
|
| 151 |
Oncogenic S1P signalling in EBV-associated nasopharyngeal carcinoma activates AKT and promotes cell migration through S1P receptor 3.J Pathol. 2017 May;242(1):62-72. doi: 10.1002/path.4879. Epub 2017 Mar 15.
|
| 152 |
The B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1.PLoS Pathog. 2012 Feb;8(2):e1002516. doi: 10.1371/journal.ppat.1002516. Epub 2012 Feb 9.
|
| 153 |
Influence of SLCO1B3 haplotype-tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patients.Br J Clin Pharmacol. 2012 Apr;73(4):606-18. doi: 10.1111/j.1365-2125.2011.04123.x.
|
| 154 |
Transcription factor SOX-5 enhances nasopharyngeal carcinoma progression by down-regulating SPARC gene expression.J Pathol. 2008 Mar;214(4):445-55. doi: 10.1002/path.2299.
|
| 155 |
High SRC-1 and Twist1 expression predicts poor prognosis and promotes migration and invasion by inducing epithelial-mesenchymal transition in human nasopharyngeal carcinoma.PLoS One. 2019 Apr 11;14(4):e0215299. doi: 10.1371/journal.pone.0215299. eCollection 2019.
|
| 156 |
Mitochondrial Cholesterol in Alzheimer's Disease and Niemann-Pick Type C Disease.Front Neurol. 2019 Nov 7;10:1168. doi: 10.3389/fneur.2019.01168. eCollection 2019.
|
| 157 |
Transducin -like 1 X-linked receptor 1 suppresses cisplatin sensitivity in nasopharyngeal carcinoma via activation of NF-B pathway.Mol Cancer. 2014 Aug 22;13:195. doi: 10.1186/1476-4598-13-195.
|
| 158 |
Overexpression of transketolase protein TKTL1 is associated with occurrence and progression in nasopharyngeal carcinoma: a potential therapeutic target in nasopharyngeal carcinoma.Cancer Biol Ther. 2008 Apr;7(4):517-22. doi: 10.4161/cbt.7.4.5479. Epub 2008 Jan 2.
|
| 159 |
Silencing TRPC1 expression inhibits invasion of CNE2 nasopharyngeal tumor cells.Oncol Rep. 2012 May;27(5):1548-54. doi: 10.3892/or.2012.1695. Epub 2012 Feb 22.
|
| 160 |
Epigenetic downregulation of the ISG15-conjugating enzyme UbcH8 impairs lipolysis and correlates with poor prognosis in nasopharyngeal carcinoma.Oncotarget. 2015 Dec 1;6(38):41077-91. doi: 10.18632/oncotarget.6218.
|
| 161 |
Downregulation of G2/mitotic-specific cyclinB1 triggers autophagy via AMPK-ULK1-dependent signal pathway in nasopharyngeal carcinoma cells.Cell Death Dis. 2019 Jan 30;10(2):94. doi: 10.1038/s41419-019-1369-8.
|
| 162 |
The herpesvirus associated ubiquitin specific protease, USP7, is a negative regulator of PML proteins and PML nuclear bodies.PLoS One. 2011 Jan 31;6(1):e16598. doi: 10.1371/journal.pone.0016598.
|
| 163 |
Integrin 9 gene promoter is hypermethylated and downregulated in nasopharyngeal carcinoma.Oncotarget. 2015 Oct 13;6(31):31493-507. doi: 10.18632/oncotarget.5154.
|
| 164 |
PI3K-PKB-mTOR hyperactivation in relation to nasopharyngeal carcinoma progression and prognosis.J Cell Biochem. 2019 Jun;120(6):10186-10194. doi: 10.1002/jcb.28303. Epub 2018 Dec 23.
|
| 165 |
A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci.Nat Genet. 2010 Jul;42(7):599-603. doi: 10.1038/ng.601. Epub 2010 May 30.
|
| 166 |
Poly(I:C) induces intense expression of c-IAP2 and cooperates with an IAP inhibitor in induction of apoptosis in cancer cells.BMC Cancer. 2010 Jun 24;10:327. doi: 10.1186/1471-2407-10-327.
|
| 167 |
AMACR overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma.Tumour Biol. 2014 Aug;35(8):7983-91. doi: 10.1007/s13277-014-2065-z. Epub 2014 May 16.
|
| 168 |
Knockdown of Annexin A1 Enhances Radioresistance and Inhibits Apoptosis in Nasopharyngeal Carcinoma.Technol Cancer Res Treat. 2018 Jan 1;17:1533034617750309. doi: 10.1177/1533034617750309.
|
| 169 |
Annexin A2-mediated cancer progression and therapeutic resistance in nasopharyngeal carcinoma.J Biomed Sci. 2018 Mar 29;25(1):30. doi: 10.1186/s12929-018-0430-8.
|
| 170 |
Amyloid precursor protein silencing attenuates epithelialmesenchymal transition of nasopharyngeal carcinoma cells via inhibition of the MAPK pathway.Mol Med Rep. 2019 Jul;20(1):409-416. doi: 10.3892/mmr.2019.10293. Epub 2019 May 24.
|
| 171 |
Association of the Aquaporin 3 Gene Polymorphism (rs2231231) with Epstein-Barr Virus-Associated Cancers in China.Intervirology. 2018;61(2):72-78. doi: 10.1159/000491601. Epub 2018 Aug 15.
|
| 172 |
Over-expression of BCAT1, a c-Myc target gene, induces cell proliferation, migration and invasion in nasopharyngeal carcinoma.Mol Cancer. 2013 Jun 8;12:53. doi: 10.1186/1476-4598-12-53.
|
| 173 |
BRD7 expression and c-Myc activation forms a double-negative feedback loop that controls the cell proliferation and tumor growth of nasopharyngeal carcinoma by targeting oncogenic miR-141.J Exp Clin Cancer Res. 2018 Mar 20;37(1):64. doi: 10.1186/s13046-018-0734-2.
|
| 174 |
Baseline hemoglobin <11.0 g/dL has stronger prognostic value than anemia status in nasopharynx cancers treated with chemoradiotherapy.Int J Biol Markers. 2019 Jun;34(2):139-147. doi: 10.1177/1724600818821688. Epub 2019 Mar 13.
|
| 175 |
Parkin enhances sensitivity of paclitaxel to NPC by arresting cell cycle.Pathol Res Pract. 2020 Mar;216(3):152755. doi: 10.1016/j.prp.2019.152755. Epub 2019 Nov 18.
|
| 176 |
Tetrandrine enhances radiosensitivity through the CDC25C/CDK1/cyclin B1 pathway in nasopharyngeal carcinoma cells.Cell Cycle. 2018;17(6):671-680. doi: 10.1080/15384101.2017.1415679.
|
| 177 |
The Wnt modulator ICG?01 mediates the inhibition of nasopharyngeal carcinoma cell migration in vitro via the miR?50/CD44 axis.Int J Oncol. 2019 Mar;54(3):1010-1020. doi: 10.3892/ijo.2018.4664. Epub 2018 Dec 12.
|
| 178 |
Overexpression of N-cadherin and -catenin correlates with poor prognosis in patients with nasopharyngeal carcinoma.Oncol Lett. 2017 Mar;13(3):1725-1730. doi: 10.3892/ol.2017.5645. Epub 2017 Jan 25.
|
| 179 |
Down-regulation of MMP-2 through the p38 MAPK-NF-kappaB-dependent pathway by aloe-emodin leads to inhibition of nasopharyngeal carcinoma cell invasion.Mol Carcinog. 2010 Sep;49(9):783-97. doi: 10.1002/mc.20652.
|
| 180 |
Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma.J Exp Clin Cancer Res. 2018 Sep 20;37(1):233. doi: 10.1186/s13046-018-0873-5.
|
| 181 |
Is human papillomavirus and p16 expression associated with survival outcomes in nasopharyngeal cancer?: A systematic review and meta-analysis.Am J Otolaryngol. 2018 Nov-Dec;39(6):764-770. doi: 10.1016/j.amjoto.2018.07.005. Epub 2018 Jul 11.
|
| 182 |
BPIFB1 (LPLUNC1) inhibits radioresistance in nasopharyngeal carcinoma by inhibiting VTN expression.Cell Death Dis. 2018 Apr 1;9(4):432. doi: 10.1038/s41419-018-0409-0.
|
| 183 |
Opposed expression of IKK: loss in keratinizing carcinomas and gain in non-keratinizing carcinomas.Oncotarget. 2015 Sep 22;6(28):25499-505. doi: 10.18632/oncotarget.4548.
|
| 184 |
Starvation-induced autophagy is up-regulated via ROS-mediated ClC-3 chloride channel activation in the nasopharyngeal carcinoma cell line CNE-2Z.Biochem J. 2019 May 7;476(9):1323-1333. doi: 10.1042/BCJ20180979.
|
| 185 |
Stat3 contributes to cancer progression by regulating Jab1/Csn5 expression.Oncogene. 2017 Feb 23;36(8):1069-1079. doi: 10.1038/onc.2016.271. Epub 2016 Aug 15.
|
| 186 |
Functional polymorphism in the 5'-UTR of CR2 is associated with susceptibility to nasopharyngeal carcinoma.Oncol Rep. 2013 Jul;30(1):11-6. doi: 10.3892/or.2013.2421. Epub 2013 Apr 23.
|
| 187 |
Evaluation of Risk Factors for Nasopharyngeal Carcinoma in a High-risk Area of India, the Northeastern Region.Asian Pac J Cancer Prev. 2015;16(12):4927-35. doi: 10.7314/apjcp.2015.16.12.4927.
|
| 188 |
Overexpression of thymidylate synthetase confers an independent prognostic indicator in nasopharyngeal carcinoma.Exp Mol Pathol. 2013 Aug;95(1):83-90. doi: 10.1016/j.yexmp.2013.05.006. Epub 2013 May 28.
|
| 189 |
Circular RNA CDR1as sponges miR-7-5p to enhance E2F3 stability and promote the growth of nasopharyngeal carcinoma.Cancer Cell Int. 2019 Oct 1;19:252. doi: 10.1186/s12935-019-0959-y. eCollection 2019.
|
| 190 |
Inhibiting eEF-2 kinase-mediated autophagy enhanced the cytocidal effect of AKT inhibitor on human nasopharyngeal carcinoma.Drug Des Devel Ther. 2018 Aug 29;12:2655-2663. doi: 10.2147/DDDT.S169952. eCollection 2018.
|
| 191 |
Long Noncoding RNAs and Messenger RNAs Expression Profiles Potentially Regulated by ZBTB7A in Nasopharyngeal Carcinoma.Biomed Res Int. 2019 Jun 11;2019:7246491. doi: 10.1155/2019/7246491. eCollection 2019.
|
| 192 |
Expression of the c-fgr related transcripts in Epstein-Barr virus-associated malignancies.Int J Cancer. 1988 Jul 15;42(1):29-35. doi: 10.1002/ijc.2910420107.
|
| 193 |
Gene expression profiling of taxol-resistant nasopharyngeal carcinoma cells with siRNA-mediated FOLR1 downregulation.Int J Clin Exp Pathol. 2015 Sep 1;8(9):11314-22. eCollection 2015.
|
| 194 |
FOXC2 positively regulates YAP signaling and promotes the glycolysis of nasopharyngeal carcinoma.Exp Cell Res. 2017 Aug 1;357(1):17-24. doi: 10.1016/j.yexcr.2017.04.019. Epub 2017 Apr 19.
|
| 195 |
Downregulation of FoxM1 sensitizes nasopharyngeal carcinoma cells to cisplatin via inhibition of MRN-ATM-mediated DNA repair.BMB Rep. 2019 Mar;52(3):208-213. doi: 10.5483/BMBRep.2019.52.3.249.
|
| 196 |
Adeno-associated virus 2-mediated transduction and erythroid cell-specific expression of a human beta-globin gene.Gene Ther. 1996 Mar;3(3):223-9.
|
| 197 |
Serotonin and Dopamine Receptor Expression in Solid Tumours Including Rare Cancers.Pathol Oncol Res. 2020 Jul;26(3):1539-1547. doi: 10.1007/s12253-019-00734-w. Epub 2019 Sep 2.
|
| 198 |
IGFBP6 is a novel nasopharyngeal carcinoma prognostic biomarker.Oncotarget. 2016 Oct 18;7(42):68140-68150. doi: 10.18632/oncotarget.11886.
|
| 199 |
The association of interleukin-16 gene polymorphisms with IL-16 serum levels and risk of nasopharyngeal carcinoma in a Chinese population.Tumour Biol. 2014 Mar;35(3):1917-24. doi: 10.1007/s13277-013-1257-2. Epub 2013 Oct 8.
|
| 200 |
Significant association of the cytokine variants with head and neck cancer risk: evidence from meta-analysis.Eur Arch Otorhinolaryngol. 2018 Feb;275(2):483-496. doi: 10.1007/s00405-017-4820-4. Epub 2017 Nov 28.
|
| 201 |
Integrin 6-Targeted Positron Emission Tomography Imaging of Colorectal Cancer.ACS Omega. 2019 Sep 11;4(13):15560-15566. doi: 10.1021/acsomega.9b01920. eCollection 2019 Sep 24.
|
| 202 |
Role of the TGF/PDCD4/AP-1 Signaling Pathway in Nasopharyngeal Carcinoma and Its Relationship to Prognosis.Cell Physiol Biochem. 2017;43(4):1392-1401. doi: 10.1159/000481871. Epub 2017 Oct 11.
|
| 203 |
Clinical and biological significances of heat shock protein 90 (Hsp90) in human nasopharyngeal carcinoma cells and anti-cancer effects of Hsp90 inhibitor.Biomed Pharmacother. 2019 Dec;120:109533. doi: 10.1016/j.biopha.2019.109533. Epub 2019 Oct 18.
|
| 204 |
MiR-34b-3 and miR-449a inhibit malignant progression of nasopharyngeal carcinoma by targeting lactate dehydrogenase A.Oncotarget. 2016 Aug 23;7(34):54838-54851. doi: 10.18632/oncotarget.10761.
|
| 205 |
Lactotransferrin could be a novel independent molecular prognosticator of nasopharyngeal carcinoma.Tumour Biol. 2015 Feb;36(2):675-83. doi: 10.1007/s13277-014-2650-1. Epub 2014 Oct 7.
|
| 206 |
The RARS-MAD1L1 Fusion Gene Induces Cancer Stem Cell-like Properties and Therapeutic Resistance in Nasopharyngeal Carcinoma. Clin Cancer Res. 2018 Feb 1;24(3):659-673.
|
| 207 |
The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition groove.PLoS Genet. 2012;8(11):e1003103. doi: 10.1371/journal.pgen.1003103. Epub 2012 Nov 29.
|
| 208 |
Matrix metalloproteinase 12 is induced by heterogeneous nuclear ribonucleoprotein K and promotes migration and invasion in nasopharyngeal carcinoma.BMC Cancer. 2014 May 20;14:348. doi: 10.1186/1471-2407-14-348.
|
| 209 |
Hypoxia-Induced Matrix Metalloproteinase-13 Expression in Exosomes from Nasopharyngeal Carcinoma Enhances Metastases.Cell Death Dis. 2018 Mar 7;9(3):382. doi: 10.1038/s41419-018-0425-0.
|
| 210 |
DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.Oncol Rep. 2017 Jul;38(1):317-324. doi: 10.3892/or.2017.5704. Epub 2017 Jun 6.
|
| 211 |
The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via -catenin/Cdc25c signaling and G2/M arrest.Clin Epigenetics. 2018 Feb 27;10(1):26. doi: 10.1186/s13148-018-0459-2.
|
| 212 |
Whole-exome sequencing identifies MST1R as a genetic susceptibility gene in nasopharyngeal carcinoma.Proc Natl Acad Sci U S A. 2016 Mar 22;113(12):3317-22. doi: 10.1073/pnas.1523436113. Epub 2016 Mar 7.
|
| 213 |
Characterization and Prognostic Significance of Methylthioadenosine Phosphorylase Deficiency in Nasopharyngeal Carcinoma.Medicine (Baltimore). 2015 Dec;94(49):e2271. doi: 10.1097/MD.0000000000002271.
|
| 214 |
Prognostic value and clinicopathologic significance of nm23 in various cancers: A systematic review and meta-analysis.Int J Surg. 2018 Dec;60:257-265. doi: 10.1016/j.ijsu.2018.10.035. Epub 2018 Oct 31.
|
| 215 |
MicroRNA-378g enhanced radiosensitivity of NPC cells partially by targeting protein tyrosine phosphatase SHP-1.Int J Radiat Biol. 2015;91(11):859-66. doi: 10.3109/09553002.2015.1096028. Epub 2015 Oct 16.
|
| 216 |
LncRNA SNHG1 functions as a ceRNA to antagonize the effect of miR-145a-5p on the down-regulation of NUAK1 in nasopharyngeal carcinoma cell.J Cell Mol Med. 2019 Apr;23(4):2351-2361. doi: 10.1111/jcmm.13497. Epub 2018 Mar 25.
|
| 217 |
Haplotype CGC from XPD, hOGG1 and ITGA2 polymorphisms increases the risk of nasopharyngeal carcinoma in Malaysia.PLoS One. 2017 Nov 9;12(11):e0187200. doi: 10.1371/journal.pone.0187200. eCollection 2017.
|
| 218 |
miR-181a Upregulation Promotes Radioresistance of Nasopharyngeal Carcinoma by Targeting RKIP.Onco Targets Ther. 2019 Dec 11;12:10873-10884. doi: 10.2147/OTT.S228800. eCollection 2019.
|
| 219 |
Functional PIN1 promoter polymorphisms associated with risk of nasopharyngeal carcinoma in Southern Chinese populations.Sci Rep. 2017 Jul 4;7(1):4593. doi: 10.1038/s41598-017-04156-z.
|
| 220 |
Exosomal cyclophilin A as a novel noninvasive biomarker for Epstein-Barr virus associated nasopharyngeal carcinoma.Cancer Med. 2019 Jun;8(6):3142-3151. doi: 10.1002/cam4.2185. Epub 2019 May 7.
|
| 221 |
Overexpression of Wild-Type p53-Induced Phosphatase 1 Confers Poor Prognosis of Patients with Nasopharyngeal Carcinoma.Pathol Oncol Res. 2015 Apr;21(2):283-91. doi: 10.1007/s12253-014-9819-1. Epub 2014 Jul 25.
|
| 222 |
Down-regulation of prostate stem cell antigen (PSCA) by Slug promotes metastasis in nasopharyngeal carcinoma.J Pathol. 2015 Dec;237(4):411-22. doi: 10.1002/path.4582. Epub 2015 Aug 18.
|
| 223 |
In vitro evaluation of the therapeutic effectiveness of EBV-LMP2 recombinant adenovirus vaccine in nasopharyngeal carcinoma.Biomed Pharmacother. 2020 Jan;121:109626. doi: 10.1016/j.biopha.2019.109626. Epub 2019 Nov 16.
|
| 224 |
miR-144-3p facilitates nasopharyngeal carcinoma via crosstalk with PTEN.J Cell Physiol. 2019 Aug;234(10):17912-17924. doi: 10.1002/jcp.28424. Epub 2019 Mar 4.
|
| 225 |
Over-expression of protein tyrosine phosphatase 4A2 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma. Oncotarget. 2017 Aug 24;8(44):77527-77539.
|
| 226 |
Correlation of the expressions of IGF1R-RACK1-STAT3 and Bcl-xl in nasopharyngeal carcinoma with the clinicopathological features and prognosis of nasopharyngeal carcinoma.J Cell Biochem. 2018 Feb;119(2):1931-1941. doi: 10.1002/jcb.26354. Epub 2017 Sep 18.
|
| 227 |
Circular RNA_LARP4 inhibits cell proliferation and invasion of nasopharyngeal carcinoma by repressing ROCK1.Eur Rev Med Pharmacol Sci. 2019 Nov;23(22):9915-9922. doi: 10.26355/eurrev_201911_19557.
|
| 228 |
Novel chimeric transcript RRM2-c2orf48 promotes metastasis in nasopharyngeal carcinoma.Cell Death Dis. 2017 Sep 14;8(9):e3047. doi: 10.1038/cddis.2017.402.
|
| 229 |
SAA1 polymorphisms are associated with variation in antiangiogenic and tumor-suppressive activities in nasopharyngeal carcinoma.Oncogene. 2015 Feb 12;34(7):878-89. doi: 10.1038/onc.2014.12. Epub 2014 Mar 10.
|
| 230 |
MiR-122-5p suppresses cell proliferation, migration and invasion by targeting SATB1 in nasopharyngeal carcinoma.Eur Rev Med Pharmacol Sci. 2019 Jan;23(2):622-629. doi: 10.26355/eurrev_201901_16876.
|
| 231 |
Promoter hypermethylation of SLIT2 is a risk factor and potential diagnostic biomarker for nasopharyngeal carcinoma.Gene. 2018 Feb 20;644:74-79. doi: 10.1016/j.gene.2017.10.059. Epub 2017 Nov 8.
|
| 232 |
MicroRNA-663b promotes cell proliferation and epithelial mesenchymal transition by directly targeting SMAD7 in nasopharyngeal carcinoma.Exp Ther Med. 2018 Oct;16(4):3129-3134. doi: 10.3892/etm.2018.6576. Epub 2018 Aug 7.
|
| 233 |
SPLUNC1 and MLL3 regulate cancer stem cells in nasopharyngeal carcinoma.J BUON. 2019 Jul-Aug;24(4):1700-1705.
|
| 234 |
Serglycin expression: An independent marker of distant metastases in nasopharyngeal carcinoma.Head Neck. 2016 Jan;38(1):21-8. doi: 10.1002/hed.23841. Epub 2015 Jan 27.
|
| 235 |
Silencing Op18/stathmin by RNA Interference Promotes the Sensitivity of Nasopharyngeal Carcinoma Cells to Taxol and High-Grade Differentiation of Xenografted Tumours in Nude Mice.Basic Clin Pharmacol Toxicol. 2016 Dec;119(6):611-620. doi: 10.1111/bcpt.12633. Epub 2016 Jul 12.
|
| 236 |
Clinical significance of elevated spleen tyrosine kinase expression in nasopharyngeal carcinoma.Head Neck. 2012 Oct;34(10):1456-64. doi: 10.1002/hed.21953. Epub 2012 Jan 27.
|
| 237 |
Activating enhancer-binding protein-2 induces cyclooxygenase-2 expression and promotes nasopharyngeal carcinoma growth.Oncotarget. 2015 Mar 10;6(7):5005-21. doi: 10.18632/oncotarget.3215.
|
| 238 |
Thyroid hormone receptor alpha 1 (c-erb A alpha 1) suppressed transforming phenotype of nasopharyngeal carcinoma cell line.Cancer Lett. 2002 Oct 28;184(2):149-56. doi: 10.1016/s0304-3835(02)00206-9.
|
| 239 |
Overexpression of Tiam1 is associated with malignant phenotypes of nasopharyngeal carcinoma.Oncol Rep. 2014 Aug;32(2):607-18. doi: 10.3892/or.2014.3241. Epub 2014 Jun 6.
|
| 240 |
Knockdown of TKTL1 additively complements cisplatin-induced cytotoxicity in nasopharyngeal carcinoma cells by regulating the levels of NADPH and ribose-5-phosphate.Biomed Pharmacother. 2017 Jan;85:672-678. doi: 10.1016/j.biopha.2016.11.078. Epub 2016 Dec 6.
|
| 241 |
miR-429 suppresses cell proliferation, migration and invasion in nasopharyngeal carcinoma by downregulation of TLN1.Cancer Cell Int. 2019 Apr 30;19:115. doi: 10.1186/s12935-019-0831-0. eCollection 2019.
|
| 242 |
Lentivirus-mediated RNA interference targeting Bax inhibitor-1 suppresses ex vivo cell proliferation and in vivo tumor growth of nasopharyngeal carcinoma.Hum Gene Ther. 2011 Oct;22(10):1201-8. doi: 10.1089/hum.2010.178. Epub 2011 May 5.
|
| 243 |
Functional characterization of TRPM7 in nasopharyngeal carcinoma and its knockdown effects on tumorigenesis.Tumour Biol. 2016 Jul;37(7):9273-83. doi: 10.1007/s13277-015-4636-z. Epub 2016 Jan 15.
|
| 244 |
Thymidine phosphorylase mRNA stability and protein levels are increased through ERK-mediated cytoplasmic accumulation of hnRNP K in nasopharyngeal carcinoma cells.Oncogene. 2009 Apr 30;28(17):1904-15. doi: 10.1038/onc.2009.55. Epub 2009 Mar 30.
|
| 245 |
Promoter hypermethylation of tumor suppressor genes in serum as potential biomarker for the diagnosis of nasopharyngeal carcinoma.Cancer Epidemiol. 2013 Oct;37(5):708-13. doi: 10.1016/j.canep.2013.05.012. Epub 2013 Jun 20.
|
| 246 |
EZH2 suppresses the nucleotide excision repair in nasopharyngeal carcinoma by silencing XPA gene.Mol Carcinog. 2017 Feb;56(2):447-463. doi: 10.1002/mc.22507. Epub 2016 Jun 10.
|
| 247 |
CD70 expression in thymic carcinoma.Am J Surg Pathol. 2000 May;24(5):742-6. doi: 10.1097/00000478-200005000-00014.
|
| 248 |
Whole-exome sequencing identifies multiple loss-of-function mutations of NF-B pathway regulators in nasopharyngeal carcinoma.Proc Natl Acad Sci U S A. 2016 Oct 4;113(40):11283-11288. doi: 10.1073/pnas.1607606113. Epub 2016 Sep 19.
|
| 249 |
The effect on radioresistance of manganese superoxide dismutase in nasopharyngeal carcinoma.Oncol Rep. 2010 Apr;23(4):1005-11. doi: 10.3892/or_00000726.
|
| 250 |
The FOXM1-ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells.Cell Death Dis. 2017 Mar 9;8(3):e2659. doi: 10.1038/cddis.2017.53.
|
| 251 |
Inhibition of ZIP4 reverses epithelial-to-mesenchymal transition and enhances the radiosensitivity in human nasopharyngeal carcinoma cells.Cell Death Dis. 2019 Aug 5;10(8):588. doi: 10.1038/s41419-019-1807-7.
|
| 252 |
Overexpression of AKR1B10 in nasopharyngeal carcinoma as a potential biomarker.Cancer Biomark. 2016;16(1):127-35. doi: 10.3233/CBM-150548.
|
| 253 |
The uS8, uS4, eS31, and uL14 Ribosomal Protein Genes Are Dysregulated in Nasopharyngeal Carcinoma Cell Lines.Biomed Res Int. 2017;2017:4876954. doi: 10.1155/2017/4876954. Epub 2017 Jul 16.
|
| 254 |
Metabolic Phase I (CYPs) and Phase II (GSTs) Gene Polymorphisms and Their Interaction with Environmental Factors in Nasopharyngeal Cancer from the Ethnic Population of Northeast India.Pathol Oncol Res. 2019 Jan;25(1):33-44. doi: 10.1007/s12253-017-0309-0. Epub 2017 Sep 26.
|
| 255 |
Oncorine, the World First Oncolytic Virus Medicine and its Update in China.Curr Cancer Drug Targets. 2018;18(2):171-176. doi: 10.2174/1568009618666171129221503.
|
| 256 |
Overexpression of asparagine synthetase and matrix metalloproteinase 19 confers cisplatin sensitivity in nasopharyngeal carcinoma cells.Mol Cancer Ther. 2013 Oct;12(10):2157-66. doi: 10.1158/1535-7163.MCT-12-1190. Epub 2013 Aug 16.
|
| 257 |
Inactivation of LARS2, located at the commonly deleted region 3p21.3, by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.Acta Biochim Biophys Sin (Shanghai). 2009 Jan;41(1):54-62. doi: 10.1093/abbs/gmn006.
|
| 258 |
Nicotinamide N-methyltransferase overexpression is associated with Akt phosphorylation and indicates worse prognosis in patients with nasopharyngeal carcinoma.Tumour Biol. 2013 Dec;34(6):3923-31. doi: 10.1007/s13277-013-0980-z. Epub 2013 Jul 11.
|
| 259 |
Evaluation of UDP-glucuronosyltransferase 2B17 (UGT2B17) and dihydrofolate reductase (DHFR) genes deletion and the expression level of NGX6 mRNA in breast cancer.Mol Biol Rep. 2012 Dec;39(12):10531-9. doi: 10.1007/s11033-012-1938-8. Epub 2012 Oct 7.
|
| 260 |
Loss of atypical chemokine receptor 4 facilitates C-C motif chemokine ligand 21-mediated tumor growth and invasion in nasopharyngeal carcinoma.Exp Ther Med. 2019 Jan;17(1):613-620. doi: 10.3892/etm.2018.7007. Epub 2018 Nov 23.
|
| 261 |
Correlation of five secretory proteins with the nasopharyngeal carcinoma metastasis and the clinical applications.Oncotarget. 2017 Apr 25;8(17):29383-29394. doi: 10.18632/oncotarget.14725.
|
| 262 |
Long non-coding RNA LINC01133 mediates nasopharyngeal carcinoma tumorigenesis by binding to YBX1.Am J Cancer Res. 2019 Apr 1;9(4):779-790. eCollection 2019.
|
| 263 |
LZTS2 inhibits PI3K/AKT activation and radioresistance in nasopharyngeal carcinoma by interacting with p85.Cancer Lett. 2018 Apr 28;420:38-48. doi: 10.1016/j.canlet.2018.01.067. Epub 2018 Jan 31.
|
| 264 |
Discrepant lesion size estimated on T1- and fat-suppressed T2-weighted MRI: diagnostic value for differentiation between inflammatory pseudotumor and carcinoma of the nasopharynx.Diagn Interv Radiol. 2017 May-Jun;23(3):199-205. doi: 10.5152/dir.2017.16241.
|
| 265 |
Upregulation of lncRNA HAGLROS enhances the development of nasopharyngeal carcinoma via modulating miR-100/ATG14 axis-mediated PI3K/AKT/mTOR signals.Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):3043-3052. doi: 10.1080/21691401.2019.1640233.
|
| 266 |
Potentially functional variants of autophagy-related genes are associated with the efficacy and toxicity of radiotherapy in patients with nasopharyngeal carcinoma.Mol Genet Genomic Med. 2019 Dec;7(12):e1030. doi: 10.1002/mgg3.1030. Epub 2019 Nov 6.
|
| 267 |
In vitro cytotoxicity evaluation of thiourea derivatives bearing Salix sp. constituent against HK-1 cell lines.Nat Prod Res. 2020 Jun;34(11):1505-1514. doi: 10.1080/14786419.2018.1517120. Epub 2018 Dec 3.
|
| 268 |
Expression of BARF1 gene encoded by Epstein-Barr virus in nasopharyngeal carcinoma biopsies.Cancer Res. 2000 Oct 1;60(19):5584-8.
|
| 269 |
Treatment Response Prediction of Nasopharyngeal Carcinoma Based on Histogram Analysis of Diffusional Kurtosis Imaging.AJNR Am J Neuroradiol. 2019 Feb;40(2):326-333. doi: 10.3174/ajnr.A5925. Epub 2019 Jan 10.
|
| 270 |
Constitutive activation of distinct NF-B signals in EBV-associated nasopharyngeal carcinoma.J Pathol. 2013 Nov;231(3):311-22. doi: 10.1002/path.4239. Epub 2013 Sep 3.
|
| 271 |
Inactivation of 3-hydroxybutyrate dehydrogenase type 2 promotes proliferation and metastasis of nasopharyngeal carcinoma by iron retention.Br J Cancer. 2020 Jan;122(1):102-110. doi: 10.1038/s41416-019-0638-8. Epub 2019 Dec 10.
|
| 272 |
BEX3 contributes to cisplatin chemoresistance in nasopharyngeal carcinoma.Cancer Med. 2017 Feb;6(2):439-451. doi: 10.1002/cam4.982. Epub 2017 Jan 13.
|
| 273 |
Expression and clinical significance of basic transcription factor 3 in nasopharyngeal carcinoma.Oncol Lett. 2019 Jan;17(1):789-796. doi: 10.3892/ol.2018.9699. Epub 2018 Nov 14.
|
| 274 |
Pretreatment combination of platelet counts and neutrophil-lymphocyte ratio predicts survival of nasopharyngeal cancer patients receiving intensity-modulated radiotherapy.Onco Targets Ther. 2017 May 26;10:2751-2760. doi: 10.2147/OTT.S137000. eCollection 2017.
|
| 275 |
Caspase 12 degrades IB protein and enhances MMP-9 expression in human nasopharyngeal carcinoma cell invasion.Oncotarget. 2017 May 16;8(20):33515-33526. doi: 10.18632/oncotarget.16535.
|
| 276 |
Epstein-Barr virus-encoded LMP2A stimulates migration of nasopharyngeal carcinoma cells via the EGFR/Ca(2+)/calpain/ITG4 axis.Biol Open. 2017 Jun 15;6(6):914-922. doi: 10.1242/bio.024646.
|
| 277 |
Decreased macrophage inflammatory protein (MIP)-1 and MIP-1 increase the risk of developing nasopharyngeal carcinoma.Cancer Commun (Lond). 2018 Apr 3;38(1):7. doi: 10.1186/s40880-018-0279-y.
|
| 278 |
Differences in cancer gene copy number alterations between Epstein-Barr virus-positive and Epstein-Barr virus-negative nasopharyngeal carcinoma.Head Neck. 2018 Sep;40(9):1986-1998. doi: 10.1002/hed.25195. Epub 2018 Jun 21.
|
| 279 |
Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan.Clin Cancer Res. 2018 Mar 15;24(6):1305-1314. doi: 10.1158/1078-0432.CCR-17-1929. Epub 2018 Jan 4.
|
| 280 |
Elevated expression of CD93 promotes angiogenesis and tumor growth in nasopharyngeal carcinoma.Biochem Biophys Res Commun. 2016 Aug 5;476(4):467-474. doi: 10.1016/j.bbrc.2016.05.146. Epub 2016 May 30.
|
| 281 |
Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.Med Sci Monit. 2016 Jun 28;22:2215-34. doi: 10.12659/msm.896047.
|
| 282 |
VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma.Cell Death Dis. 2019 Apr 3;10(4):305. doi: 10.1038/s41419-019-1457-9.
|
| 283 |
Cofilin-2 Acts as a Marker for Predicting Radiotherapy Response and Is a Potential Therapeutic Target in Nasopharyngeal Carcinoma.Med Sci Monit. 2018 Apr 17;24:2317-2329. doi: 10.12659/msm.909832.
|
| 284 |
An extended genome-wide association study identifies novel susceptibility loci for nasopharyngeal carcinoma.Hum Mol Genet. 2016 Aug 15;25(16):3626-3634. doi: 10.1093/hmg/ddw200. Epub 2016 Jul 19.
|
| 285 |
Loss of Cirbp expression is correlated with the malignant progression and poor prognosis in nasopharyngeal carcinoma.Cancer Manag Res. 2019 Jul 24;11:6959-6969. doi: 10.2147/CMAR.S211389. eCollection 2019.
|
| 286 |
Effects of CKMT1 on radiosensitivity of nasopharyngeal carcinoma cells.Int J Radiat Biol. 2019 May;95(5):597-606. doi: 10.1080/09553002.2019.1554919. Epub 2019 Jan 4.
|
| 287 |
Impact of adaptive intensity-modulated radiotherapy on the neutrophil-to-lymphocyte ratio in patients with nasopharyngeal carcinoma.Radiat Oncol. 2019 Aug 22;14(1):151. doi: 10.1186/s13014-019-1350-9.
|
| 288 |
Pinostilbene Hydrate Inhibits the Migration and Invasion of Human Nasopharyngeal Carcinoma Cells by Downregulating MMP-2 Expression and Suppressing Epithelial-Mesenchymal Transition Through the Mitogen-Activated Protein Kinase Signaling Pathways.Front Oncol. 2019 Dec 3;9:1364. doi: 10.3389/fonc.2019.01364. eCollection 2019.
|
| 289 |
Inactivation of the tight junction gene CLDN11 by aberrant hypermethylation modulates tubulins polymerization and promotes cell migration in nasopharyngeal carcinoma.J Exp Clin Cancer Res. 2018 May 10;37(1):102. doi: 10.1186/s13046-018-0754-y.
|
| 290 |
Differences in the expression profiles of claudin proteins in human nasopharyngeal carcinoma compared with non-neoplastic mucosa.Diagn Pathol. 2018 Feb 5;13(1):11. doi: 10.1186/s13000-018-0685-0.
|
| 291 |
Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.PLoS One. 2018 Mar 1;13(3):e0193171. doi: 10.1371/journal.pone.0193171. eCollection 2018.
|
| 292 |
LncRNA CCAT1 modulates the sensitivity of paclitaxel in nasopharynx cancers cells via miR-181a/CPEB2 axis.Cell Cycle. 2017 Apr 18;16(8):795-801. doi: 10.1080/15384101.2017.1301334. Epub 2017 Mar 30.
|
| 293 |
Low expression of Cyfip1 may be a potential biomarker in nasopharyngeal carcinoma.Neoplasma. 2018;65(2):292-295. doi: 10.4149/neo_2018_170318N194.
|
| 294 |
MicroRNA-200c promotes tumor cell proliferation and migration by directly targeting dachshund family transcription factor 1 by the Wnt/-catenin signaling pathway in nasopharyngeal carcinoma.Anticancer Drugs. 2019 Mar;30(3):218-224. doi: 10.1097/CAD.0000000000000713.
|
| 295 |
Effects of DACT1 methylation status on invasion and metastasis of nasopharyngeal carcinoma.Biol Res. 2019 Jun 10;52(1):31. doi: 10.1186/s40659-019-0238-3.
|
| 296 |
Molecular profile of nasopharyngeal carcinoma: analysing tumour suppressor gene promoter hypermethylation by multiplex ligation-dependent probe amplification.J Clin Pathol. 2018 Apr;71(4):351-359. doi: 10.1136/jclinpath-2017-204661. Epub 2017 Sep 11.
|
| 297 |
Cyclin-Dependent Kinase Inhibitor 3 Promotes Cancer Cell Proliferation and Tumorigenesis in Nasopharyngeal Carcinoma by Targeting p27.Oncol Res. 2017 Nov 2;25(9):1431-1440. doi: 10.3727/096504017X14835311718295. Epub 2017 Jan 20.
|
| 298 |
DHRS2 mediates cell growth inhibition induced by Trichothecin in nasopharyngeal carcinoma.J Exp Clin Cancer Res. 2019 Jul 10;38(1):300. doi: 10.1186/s13046-019-1301-1.
|
| 299 |
Natural Variations in BRLF1 Promoter Contribute to the Elevated Reactivation Level of Epstein-Barr Virus in Endemic Areas of Nasopharyngeal Carcinoma.EBioMedicine. 2018 Nov;37:101-109. doi: 10.1016/j.ebiom.2018.10.065. Epub 2018 Nov 9.
|
| 300 |
ELF-1 expression in nasopharyngeal carcinoma facilitates proliferation and metastasis of cancer cells via modulation of CCL2/CCR2 signaling.Cancer Manag Res. 2019 Jun 6;11:5243-5254. doi: 10.2147/CMAR.S196355. eCollection 2019.
|
| 301 |
Probe-based confocal laser endomicroscopy for diagnosis of nasopharyngeal carcinoma in vivo.Laryngoscope. 2019 Apr;129(4):897-902. doi: 10.1002/lary.27450. Epub 2018 Aug 27.
|
| 302 |
Human Ribosomal Proteins RPeL27, RPeL43, and RPeL41 Are Upregulated in Nasopharyngeal Carcinoma Cell Lines.Dis Markers. 2016;2016:5179594. doi: 10.1155/2016/5179594. Epub 2016 Nov 28.
|
| 303 |
CircHIPK3 promotes proliferation and invasion in nasopharyngeal carcinoma by abrogating miR-4288-induced ELF3 inhibition.J Cell Physiol. 2019 Feb;234(2):1699-1706. doi: 10.1002/jcp.27041. Epub 2018 Aug 2.
|
| 304 |
Exosomal miR-24-3p impedes T-cell function by targeting FGF11 and serves as a potential prognostic biomarker for nasopharyngeal carcinoma.J Pathol. 2016 Nov;240(3):329-340. doi: 10.1002/path.4781.
|
| 305 |
Frequent c-myc and Int-2 overrepresentations in nasopharyngeal carcinoma.Hum Pathol. 2000 Feb;31(2):169-78. doi: 10.1016/s0046-8177(00)80216-6.
|
| 306 |
Chromatin remodeling factor LSH affects fumarate hydratase as a cancer driver.Chin J Cancer. 2016 Jul 30;35(1):72. doi: 10.1186/s40880-016-0138-7.
|
| 307 |
High FMNL3 expression promotes nasopharyngeal carcinoma cell metastasis: role in TGF-1-induced epithelia-to-mesenchymal transition.Sci Rep. 2017 Feb 15;7:42507. doi: 10.1038/srep42507.
|
| 308 |
Correlation between the expression of miR150 and FOXO4 and the local recurrence and metastasis of nasopharyngeal carcinoma after intensive radiotherapy.J BUON. 2018 Nov-Dec;23(6):1671-1678.
|
| 309 |
GALNT7, a target of miR-494, participates in the oncogenesis of nasopharyngeal carcinoma.Tumour Biol. 2016 Apr;37(4):4559-67. doi: 10.1007/s13277-015-4281-6. Epub 2015 Oct 27.
|
| 310 |
FMNL1 mediates nasopharyngeal carcinoma cell aggressiveness by epigenetically upregulating MTA1.Oncogene. 2018 Nov;37(48):6243-6258. doi: 10.1038/s41388-018-0351-8. Epub 2018 Jul 16.
|
| 311 |
Epstein-Barr virus encoded microRNA BART7 regulates radiation sensitivity of nasopharyngeal carcinoma.Oncotarget. 2017 Mar 21;8(12):20297-20308. doi: 10.18632/oncotarget.15526.
|
| 312 |
High pretreatment serum gamma-glutamyl transpeptidase predicts an inferior outcome in nasopharyngeal carcinoma.Oncotarget. 2017 Jun 28;8(40):67651-67662. doi: 10.18632/oncotarget.18798. eCollection 2017 Sep 15.
|
| 313 |
The Glypican-4 Gene Polymorphism rs1048369 and Susceptibility to Epstein-Barr Virus-Positive and -Negative Nasopharyngeal Carcinoma in Northern China.Oncol Res Treat. 2019;42(11):572-579. doi: 10.1159/000502753. Epub 2019 Sep 13.
|
| 314 |
Clinicopathological and prognostic significance of GPx2 protein expression in nasopharyngeal carcinoma.Cancer Biomark. 2017 Jul 4;19(3):335-340. doi: 10.3233/CBM-160542.
|
| 315 |
Retrospective dosimetry study of intensity-modulated radiation therapy for nasopharyngeal carcinoma: measurement-guided dose reconstruction and analysis.Radiat Oncol. 2018 Mar 15;13(1):42. doi: 10.1186/s13014-018-0993-2.
|
| 316 |
Real-time PCR assay for rapid detection of GSTM1 polymorphism in nasopharyngeal carcinoma patients.Asian Pac J Cancer Prev. 2008 Apr-Jun;9(2):233-7.
|
| 317 |
ATR activated by EB virus facilitates chemotherapy resistance to cisplatin or 5-fluorouracil in human nasopharyngeal carcinoma.Cancer Manag Res. 2019 Jan 9;11:573-585. doi: 10.2147/CMAR.S187099. eCollection 2019.
|
| 318 |
Histone acetyltransferase 1 up regulates Bcl2L12 expression in nasopharyngeal cancer cells.Arch Biochem Biophys. 2018 May 15;646:72-79. doi: 10.1016/j.abb.2018.03.040. Epub 2018 Apr 3.
|
| 319 |
HMG-box transcription factor 1: a positive regulator of the G1/S transition through the Cyclin-CDK-CDKI molecular network in nasopharyngeal carcinoma.Cell Death Dis. 2018 Jan 24;9(2):100. doi: 10.1038/s41419-017-0175-4.
|
| 320 |
Homozygous deletion of the death receptor DR4 gene in a nasopharyngeal cancer cell line is associated with TRAIL resistance.Int J Oncol. 2000 May;16(5):917-25. doi: 10.3892/ijo.16.5.917.
|
| 321 |
HOPX hypermethylation promotes metastasis via activating SNAIL transcription in nasopharyngeal carcinoma.Nat Commun. 2017 Feb 1;8:14053. doi: 10.1038/ncomms14053.
|
| 322 |
Repression of Hox genes by LMP1 in nasopharyngeal carcinoma and modulation of glycolytic pathway genes by HoxC8.Oncogene. 2015 Dec 10;34(50):6079-91. doi: 10.1038/onc.2015.53. Epub 2015 Mar 9.
|
| 323 |
Isoprenylcysteine carboxylmethyltransferase is associated with nasopharyngeal carcinoma chemoresistance and Ras activation.Biochem Biophys Res Commun. 2019 Aug 27;516(3):784-789. doi: 10.1016/j.bbrc.2019.06.074. Epub 2019 Jun 26.
|
| 324 |
Triptonide inhibits human nasopharyngeal carcinoma cell growth via disrupting Lnc-RNA THOR-IGF2BP1 signaling.Cancer Lett. 2019 Feb 28;443:13-24. doi: 10.1016/j.canlet.2018.11.028. Epub 2018 Nov 29.
|
| 325 |
Long non-coding RNA DANCR stabilizes HIF-1 and promotes metastasis by interacting with NF90/NF45 complex in nasopharyngeal carcinoma.Theranostics. 2018 Nov 10;8(20):5676-5689. doi: 10.7150/thno.28538. eCollection 2018.
|
| 326 |
Adenovirus-mediated co-expression of ING4 and PTEN cooperatively enhances their antitumor activity in human hepatocellular carcinoma cells.Acta Biochim Biophys Sin (Shanghai). 2016 Aug;48(8):704-13. doi: 10.1093/abbs/gmw062. Epub 2016 Jul 14.
|
| 327 |
Insulinoma-associated protein 1 controls nasopharyngeal carcinoma to radiotherapy by modulating cyclin D1-dependent DNA repair machinery.Carcinogenesis. 2020 May 14;41(3):326-333. doi: 10.1093/carcin/bgz101.
|
| 328 |
Nasopharyngeal carcinoma super-enhancer-driven ETV6 correlates with prognosis.Proc Natl Acad Sci U S A. 2017 Sep 5;114(36):9683-9688. doi: 10.1073/pnas.1705236114. Epub 2017 Aug 22.
|
| 329 |
The developmental transcription factor IRF6 attenuates ABCG2 gene expression and distinctively reverses stemness phenotype in nasopharyngeal carcinoma.Cancer Lett. 2018 Sep 1;431:230-243. doi: 10.1016/j.canlet.2017.10.016. Epub 2017 Oct 27.
|
| 330 |
MicroRNA-101 inhibits invasion and angiogenesis through targeting ITGA3 and its systemic delivery inhibits lung metastasis in nasopharyngeal carcinoma.Cell Death Dis. 2017 Jan 19;8(1):e2566. doi: 10.1038/cddis.2016.486.
|
| 331 |
Genome-wide CRISPR-based gene knockout screens reveal cellular factors and pathways essential for nasopharyngeal carcinoma.J Biol Chem. 2019 Jun 21;294(25):9734-9745. doi: 10.1074/jbc.RA119.008793. Epub 2019 May 9.
|
| 332 |
Overexpression of Kinesin Family Member 20A Correlates with Disease Progression and Poor Prognosis in Human Nasopharyngeal Cancer: A Retrospective Analysis of 105 Patients.PLoS One. 2017 Jan 12;12(1):e0169280. doi: 10.1371/journal.pone.0169280. eCollection 2017.
|
| 333 |
Upregulation of KLHDC4 Predicts a Poor Prognosis in Human Nasopharyngeal Carcinoma.PLoS One. 2016 Mar 31;11(3):e0152820. doi: 10.1371/journal.pone.0152820. eCollection 2016.
|
| 334 |
Proteomic Characterization Reveals a Molecular Portrait of Nasopharyngeal Carcinoma Differentiation.J Cancer. 2017 Feb 11;8(4):570-577. doi: 10.7150/jca.17414. eCollection 2017.
|
| 335 |
MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/-catenin signaling pathway by down-regulating LHX2.J Exp Clin Cancer Res. 2019 Feb 21;38(1):97. doi: 10.1186/s13046-019-1023-4.
|
| 336 |
MiR-183 overexpression inhibits tumorigenesis and enhances DDP-induced cytotoxicity by targeting MTA1 in nasopharyngeal carcinoma.Tumour Biol. 2017 Jun;39(6):1010428317703825. doi: 10.1177/1010428317703825.
|
| 337 |
Quantitative Proteomic Analysis Identifies MAPK15 as a Potential Regulator of Radioresistance in Nasopharyngeal Carcinoma Cells.Front Oncol. 2018 Nov 22;8:548. doi: 10.3389/fonc.2018.00548. eCollection 2018.
|
| 338 |
MIIP gene expression is associated with radiosensitivity in human nasopharyngeal carcinoma cells.Oncol Lett. 2018 Jun;15(6):9471-9479. doi: 10.3892/ol.2018.8524. Epub 2018 Apr 18.
|
| 339 |
Matrix association region/scaffold attachment region: the crucial player in defining the positions of chromosome breaks mediated by bile acid-induced apoptosis in nasopharyngeal epithelial cells.BMC Med Genomics. 2019 Jan 15;12(1):9. doi: 10.1186/s12920-018-0465-4.
|
| 340 |
Calcinosis and malignancy are rare in Chinese adult patients with myositis and nuclear matrix protein 2 antibodies identified by an unlabeled immunoprecipitation assay.Clin Rheumatol. 2018 Oct;37(10):2731-2739. doi: 10.1007/s10067-018-4216-x. Epub 2018 Jul 23.
|
| 341 |
MORF4L1 suppresses cell proliferation, migration and invasion by increasing p21 and E-cadherin expression in nasopharyngeal carcinoma.Oncol Lett. 2019 Jan;17(1):294-302. doi: 10.3892/ol.2018.9588. Epub 2018 Oct 16.
|
| 342 |
Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy.BMC Cancer. 2016 Mar 7;16:190. doi: 10.1186/s12885-016-2190-8.
|
| 343 |
Rta-IgG as a biomarker for diagnosis and post treatment prognostic of nasopharyngeal carcinoma.Cancer Biomark. 2016;16(3):467-76. doi: 10.3233/CBM-160586.
|
| 344 |
In vivo three-dimensional evaluation of tumour hypoxia in nasopharyngeal carcinomas using FMT-CT and MSOT.Eur J Nucl Med Mol Imaging. 2020 May;47(5):1027-1038. doi: 10.1007/s00259-019-04526-x. Epub 2019 Nov 8.
|
| 345 |
Knockdown Rab11-FIP2 inhibits migration and invasion of nasopharyngeal carcinoma via suppressing Rho GTPase signaling.J Cell Biochem. 2020 Feb;121(2):1072-1086. doi: 10.1002/jcb.29344. Epub 2019 Aug 26.
|
| 346 |
High Expression of LINC01420 indicates an unfavorable prognosis and modulates cell migration and invasion in nasopharyngeal carcinoma.J Cancer. 2017 Jan 1;8(1):97-103. doi: 10.7150/jca.16819. eCollection 2017.
|
| 347 |
Reducing NETO2 expression prevents human nasopharyngeal carcinoma (NPC) progression by suppressing metastasis and inducingapoptosis.Biochem Biophys Res Commun. 2019 May 28;513(2):494-501. doi: 10.1016/j.bbrc.2019.03.061. Epub 2019 Apr 8.
|
| 348 |
IKBB tumor suppressive role in nasopharyngeal carcinoma via NF-B-mediated signalling.Int J Cancer. 2016 Jan 1;138(1):160-70. doi: 10.1002/ijc.29702. Epub 2015 Aug 10.
|
| 349 |
Whole-Exome Sequencing of Nasopharyngeal Carcinoma Families Reveals Novel Variants Potentially Involved in Nasopharyngeal Carcinoma.Sci Rep. 2019 Jul 9;9(1):9916. doi: 10.1038/s41598-019-46137-4.
|
| 350 |
Epstein-Barr virus-coded miR-BART13 promotes nasopharyngeal carcinoma cell growth and metastasis via targeting of the NKIRAS2/NF-B pathway.Cancer Lett. 2019 Apr 10;447:33-40. doi: 10.1016/j.canlet.2019.01.022. Epub 2019 Jan 23.
|
| 351 |
MiR-20a-5p promotes radio-resistance by targeting NPAS2 in nasopharyngeal cancer cells.Oncotarget. 2017 Nov 11;8(62):105873-105881. doi: 10.18632/oncotarget.22411. eCollection 2017 Dec 1.
|
| 352 |
Elevated SUV39H2 attributes to the progression of nasopharyngeal carcinoma via regulation of NRIP1.Biochem Biophys Res Commun. 2019 Mar 5;510(2):290-295. doi: 10.1016/j.bbrc.2019.01.092. Epub 2019 Jan 30.
|
| 353 |
Inhibition of the Numb/Notch signaling pathway increases radiation sensitivity in human nasopharyngeal carcinoma cells.Kaohsiung J Med Sci. 2019 Aug;35(8):474-485. doi: 10.1002/kjm2.12087. Epub 2019 Jul 4.
|
| 354 |
Opa interacting protein 5 promotes metastasis of nasopharyngeal carcinoma cells by promoting EMT via modulation of JAK2/STAT3 signal.Eur Rev Med Pharmacol Sci. 2019 Jan;23(2):613-621. doi: 10.26355/eurrev_201901_16875.
|
| 355 |
Identification of key genes involved in nasopharyngeal carcinoma.Braz J Otorhinolaryngol. 2017 Nov-Dec;83(6):670-676. doi: 10.1016/j.bjorl.2016.09.003. Epub 2016 Sep 26.
|
| 356 |
Therapeutic targeting of CBP/-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin.Sci Rep. 2015 Apr 21;5:9979. doi: 10.1038/srep09979.
|
| 357 |
Aberrant promoter methylation reduced the expression of protocadherin 17 in nasopharyngeal cancer.Biochem Cell Biol. 2019 Aug;97(4):364-368. doi: 10.1139/bcb-2017-0343. Epub 2018 Aug 30.
|
| 358 |
Blocking podoplanin suppresses growth and pulmonary metastasis of human malignant melanoma.BMC Cancer. 2019 Jun 17;19(1):599. doi: 10.1186/s12885-019-5808-9.
|
| 359 |
Dinitrosopiperazine-decreased PKP3 through upregulating miR-149 participates in nasopharyngeal carcinoma metastasis.Mol Carcinog. 2018 Dec;57(12):1763-1779. doi: 10.1002/mc.22895. Epub 2018 Sep 19.
|
| 360 |
Placenta specific 8 gene induces epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via the TGF-/Smad pathway.Exp Cell Res. 2019 Jan 1;374(1):172-180. doi: 10.1016/j.yexcr.2018.11.021. Epub 2018 Nov 26.
|
| 361 |
PLCD3, a flotillin2-interacting protein, is involved in proliferation, migration and invasion of nasopharyngeal carcinoma cells.Oncol Rep. 2018 Jan;39(1):45-52. doi: 10.3892/or.2017.6080. Epub 2017 Nov 6.
|
| 362 |
Interaction of phospholipid scramblase 1 with the Epstein-Barr virus protein BZLF1 represses BZLF1-mediated lytic gene transcription.J Biol Chem. 2019 Oct 11;294(41):15104-15116. doi: 10.1074/jbc.RA119.008193. Epub 2019 Aug 21.
|
| 363 |
LncRNA POU3F3 promotes cancer cell migration and invasion in nasopharyngeal carcinoma by up-regulating TGF-1.Biosci Rep. 2019 Jan 25;39(1):BSR20181632. doi: 10.1042/BSR20181632. Print 2019 Jan 31.
|
| 364 |
PNUTS mediates ionizing radiation-induced CNE-2 nasopharyngeal carcinoma cell migration, invasion, and epithelial-mesenchymal transition via the PI3K/AKT signaling pathway.Onco Targets Ther. 2019 Feb 15;12:1205-1214. doi: 10.2147/OTT.S188571. eCollection 2019.
|
| 365 |
Inhibition of DNA methyltransferase as a novel therapeutic strategy to overcome acquired resistance to dual PI3K/mTOR inhibitors.Oncotarget. 2015 Mar 10;6(7):5134-46. doi: 10.18632/oncotarget.3016.
|
| 366 |
Interaction between miR-572 and PPP2R2C, and their effects on the proliferation, migration, and invasion of nasopharyngeal carcinoma (NPC) cells.Biochem Cell Biol. 2017 Oct;95(5):578-584. doi: 10.1139/bcb-2016-0237. Epub 2017 May 19.
|
| 367 |
Serum proteomic-based analysis identifying autoantibodies against PRDX2 and PRDX3 as potential diagnostic biomarkers in nasopharyngeal carcinoma.Clin Proteomics. 2017 Feb 1;14:6. doi: 10.1186/s12014-017-9141-5. eCollection 2017.
|
| 368 |
Taxol-Resistant Gene 1 (Txr1) Mediates Oxaliplatin Resistance by Inducing Autophagy in Human Nasopharyngeal Carcinoma Cells.Med Sci Monit. 2019 Jan 16;25:475-483. doi: 10.12659/MSM.913180.
|
| 369 |
Reduced QSOX1 enhances radioresistance in nasopharyngeal carcinoma.Oncotarget. 2017 Dec 14;9(3):3230-3241. doi: 10.18632/oncotarget.23227. eCollection 2018 Jan 9.
|
| 370 |
MiR-20a-5p promotes radio-resistance by targeting Rab27B in nasopharyngeal cancer cells.Cancer Cell Int. 2017 Mar 1;17:32. doi: 10.1186/s12935-017-0389-7. eCollection 2017.
|
| 371 |
Decreased expression of the NKG2D ligand ULBP4 may be an indicator of poor prognosis in patients with nasopharyngeal carcinoma.Oncotarget. 2017 Jun 27;8(26):42007-42019. doi: 10.18632/oncotarget.14917.
|
| 372 |
Identification of nasopharyngeal carcinoma metastasis-related biomarkers by iTRAQ combined with 2D-LC-MS/MS.Oncotarget. 2016 Jun 7;7(23):34022-37. doi: 10.18632/oncotarget.9067.
|
| 373 |
RBM24 suppresses cancer progression by upregulating miR-25 to target MALAT1 in nasopharyngeal carcinoma.Cell Death Dis. 2016 Sep 1;7(9):e2352. doi: 10.1038/cddis.2016.252.
|
| 374 |
The HLA-DRB1 allele polymorphisms and nasopharyngeal carcinoma.Tumour Biol. 2016 Jun;37(6):7119-28. doi: 10.1007/s13277-016-5051-9. Epub 2016 Apr 8.
|
| 375 |
Association of regenerating gene 1A single-nucleotide polymorphisms and nasopharyngeal carcinoma susceptibility in southern Chinese population.Eur Arch Otorhinolaryngol. 2020 Jan;277(1):221-226. doi: 10.1007/s00405-019-05645-9. Epub 2019 Sep 20.
|
| 376 |
FEZF1-AS1 is a key regulator of cell cycle, epithelial-mesenchymal transition and Wnt/-catenin signaling in nasopharyngeal carcinoma cells.Biosci Rep. 2019 Jan 8;39(1):BSR20180906. doi: 10.1042/BSR20180906. Print 2019 Jan 31.
|
| 377 |
RGS17 inhibits tumorigenesis and improves 5-fluorouracil sensitivity in nasopharyngeal carcinoma.Onco Targets Ther. 2018 Nov 2;11:7591-7600. doi: 10.2147/OTT.S176002. eCollection 2018.
|
| 378 |
Prognostic value of TIGAR and LC3B protein expression in nasopharyngeal carcinoma.Cancer Manag Res. 2018 Nov 12;10:5605-5616. doi: 10.2147/CMAR.S175501. eCollection 2018.
|
| 379 |
RPA1 downregulation enhances nasopharyngeal cancer radiosensitivity via blocking RAD51 to the DNA damage site.Exp Cell Res. 2018 Oct 15;371(2):330-341. doi: 10.1016/j.yexcr.2018.08.025. Epub 2018 Aug 23.
|
| 380 |
RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma.J Cell Mol Med. 2017 Nov;21(11):2872-2883. doi: 10.1111/jcmm.13200. Epub 2017 May 30.
|
| 381 |
Downregulation of ribophorin II suppresses tumor growth, migration, and invasion of nasopharyngeal carcinoma.Onco Targets Ther. 2018 Jun 15;11:3485-3494. doi: 10.2147/OTT.S158355. eCollection 2018.
|
| 382 |
p53R2 as a novel prognostic biomarker in nasopharyngeal carcinoma.BMC Cancer. 2017 Dec 13;17(1):846. doi: 10.1186/s12885-017-3858-4.
|
| 383 |
S100P is associated with proliferation and migration in nasopharyngeal carcinoma.Oncol Lett. 2017 Jul;14(1):525-532. doi: 10.3892/ol.2017.6198. Epub 2017 May 17.
|
| 384 |
Long noncoding RNA PXN-AS1-L promotes the malignancy of nasopharyngeal carcinoma cells via upregulation of SAPCD2.Cancer Med. 2019 Aug;8(9):4278-4291. doi: 10.1002/cam4.2227. Epub 2019 Jun 7.
|
| 385 |
Enhanced expression of SETDB1 possesses prognostic value and promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma.Oncol Rep. 2018 Aug;40(2):1017-1025. doi: 10.3892/or.2018.6490. Epub 2018 Jun 14.
|
| 386 |
TET1 exerts its anti-tumor functions via demethylating DACT2 and SFRP2 to antagonize Wnt/-catenin signaling pathway in nasopharyngeal carcinoma cells.Clin Epigenetics. 2018 Aug 3;10(1):103. doi: 10.1186/s13148-018-0535-7.
|
| 387 |
Hypermethylation of SHISA3 Promotes Nasopharyngeal Carcinoma Metastasis by Reducing SGSM1 Stability.Cancer Res. 2019 Feb 15;79(4):747-759. doi: 10.1158/0008-5472.CAN-18-1754. Epub 2018 Dec 20.
|
| 388 |
SHROOM2 inhibits tumor metastasis through RhoA-ROCK pathway-dependent and -independent mechanisms in nasopharyngeal carcinoma.Cell Death Dis. 2019 Jan 25;10(2):58. doi: 10.1038/s41419-019-1325-7.
|
| 389 |
Genome-wide analyses of long noncoding RNA expression profiles correlated with radioresistance in nasopharyngeal carcinoma via next-generation deep sequencing.BMC Cancer. 2016 Sep 6;16(1):719. doi: 10.1186/s12885-016-2755-6.
|
| 390 |
MicroRNA-18a promotes cancer progression through SMG1 suppression and mTOR pathway activation in nasopharyngeal carcinoma.Cell Death Dis. 2019 Oct 28;10(11):819. doi: 10.1038/s41419-019-2060-9.
|
| 391 |
Long Noncoding RNA LINC0086 Functions as a Tumor Suppressor in Nasopharyngeal Carcinoma by Targeting miR-214.Oncol Res. 2017 Aug 7;25(7):1189-1197. doi: 10.3727/096504017X14865126670075. Epub 2017 Feb 13.
|
| 392 |
MicroRNA-494-3p Promotes Cell Growth, Migration, and Invasion of Nasopharyngeal Carcinoma by Targeting Sox7.Technol Cancer Res Treat. 2018 Jan 1;17:1533033818809993. doi: 10.1177/1533033818809993.
|
| 393 |
SPINK6 Promotes Metastasis of Nasopharyngeal Carcinoma via Binding and Activation of Epithelial Growth Factor Receptor.Cancer Res. 2017 Jan 15;77(2):579-589. doi: 10.1158/0008-5472.CAN-16-1281. Epub 2016 Sep 26.
|
| 394 |
Human Leukocyte Antigen-A Allele Distribution in Nasopharyngeal Carcinoma Patients Showing Anti-Melanoma-Associated Antigen A or Synovial Sarcoma X-2 T Cell Response in Blood.Chin Med J (Engl). 2018 Jun 5;131(11):1289-1295. doi: 10.4103/0366-6999.232791.
|
| 395 |
STIL is upregulated in nasopharyngeal carcinoma tissues and promotes nasopharyngeal carcinoma proliferation, migration and invasion.Neoplasma. 2020 Jan;67(1):37-45. doi: 10.4149/neo_2019_190306N192. Epub 2019 Oct 8.
|
| 396 |
Sulforaphane promotes apoptosis, and inhibits proliferation and self-renewal of nasopharyngeal cancer cells by targeting STAT signal through miRNA-124-3p.Biomed Pharmacother. 2018 Jul;103:473-481. doi: 10.1016/j.biopha.2018.03.121. Epub 2018 Apr 24.
|
| 397 |
TAT peptide-modified cisplatin-loaded iron oxide nanoparticles for reversing cisplatin-resistant nasopharyngeal carcinoma.Biochem Biophys Res Commun. 2019 Apr 9;511(3):597-603. doi: 10.1016/j.bbrc.2019.02.117. Epub 2019 Feb 28.
|
| 398 |
TBX2 over-expression promotes nasopharyngeal cancer cell proliferation and invasion.Oncotarget. 2017 Apr 13;8(32):52699-52707. doi: 10.18632/oncotarget.17084. eCollection 2017 Aug 8.
|
| 399 |
Effects of TESTIN gene expression on proliferation and migration of the 5-8F nasopharyngeal carcinoma cell line.Asian Pac J Cancer Prev. 2015;16(6):2555-9. doi: 10.7314/apjcp.2015.16.6.2555.
|
| 400 |
TIMELESS confers cisplatin resistance in nasopharyngeal carcinoma by activating the Wnt/-catenin signaling pathway and promoting the epithelial mesenchymal transition.Cancer Lett. 2017 Aug 28;402:117-130. doi: 10.1016/j.canlet.2017.05.022. Epub 2017 Jun 3.
|
| 401 |
Matrix metalloproteinase 9 is induced by the Epstein-Barr virus BZLF1 transactivator.Clin Exp Metastasis. 1999 Jul;17(5):431-6. doi: 10.1023/a:1006699003525.
|
| 402 |
Epstein-Barr virus LMP1 modulates the malignant potential of gastric carcinoma cells involving apoptosis.Am J Pathol. 1998 Jan;152(1):63-74.
|
| 403 |
Knockdown of TMPRSS3, a Transmembrane Serine Protease, Inhibits Proliferation, Migration, and Invasion in Human Nasopharyngeal Carcinoma Cells.Oncol Res. 2018 Jan 19;26(1):95-101. doi: 10.3727/096504017X14920318811695. Epub 2017 Apr 12.
|
| 404 |
TIPE3 hypermethylation correlates with worse prognosis and promotes tumor progression in nasopharyngeal carcinoma.J Exp Clin Cancer Res. 2018 Sep 14;37(1):227. doi: 10.1186/s13046-018-0881-5.
|
| 405 |
CD137L-DCs, Potent Immune-Stimulators-History, Characteristics, and Perspectives.Front Immunol. 2019 Oct 2;10:2216. doi: 10.3389/fimmu.2019.02216. eCollection 2019.
|
| 406 |
MicroRNA-449b-5p suppresses cell proliferation, migration and invasion by targeting TPD52 in nasopharyngeal carcinoma.J Biochem. 2019 Nov 1;166(5):433-440. doi: 10.1093/jb/mvz057.
|
| 407 |
Evidence of LMP1-TRAF3 interactions in glycosphingolipid-rich complexes of lymphoblastoid and nasopharyngeal carcinoma cells.Int J Cancer. 1999 May 17;81(4):645-9. doi: 10.1002/(sici)1097-0215(19990517)81:4<645::aid-ijc22>3.0.co;2-0.
|
| 408 |
Overexpression of Mitochondria Mediator Gene TRIAP1 by miR-320b Loss Is Associated with Progression in Nasopharyngeal Carcinoma.PLoS Genet. 2016 Jul 18;12(7):e1006183. doi: 10.1371/journal.pgen.1006183. eCollection 2016 Jul.
|
| 409 |
A regulatory mutant on TRIM26 conferring the risk of nasopharyngeal carcinoma by inducing low immune response.Cancer Med. 2018 Aug;7(8):3848-3861. doi: 10.1002/cam4.1537. Epub 2018 Jun 28.
|
| 410 |
Metastasis-associated miR-23a from nasopharyngeal carcinoma-derived exosomes mediates angiogenesis by repressing a novel target gene TSGA10.Oncogene. 2018 May;37(21):2873-2889. doi: 10.1038/s41388-018-0183-6. Epub 2018 Mar 9.
|
| 411 |
TSPAN8 serves as a prognostic marker involving Akt/MAPK pathway in nasopharyngeal carcinoma.Ann Transl Med. 2019 Sep;7(18):470. doi: 10.21037/atm.2019.08.02.
|
| 412 |
High-resolution melting analysis of ADAMTS18 methylation levels in gastric, colorectal and pancreatic cancers.Med Oncol. 2010 Sep;27(3):998-1004. doi: 10.1007/s12032-009-9323-8. Epub 2009 Oct 6.
|
| 413 |
The potent tumor suppressor miR-497 inhibits cancer phenotypes in nasopharyngeal carcinoma by targeting ANLN and HSPA4L.Oncotarget. 2015 Nov 3;6(34):35893-907. doi: 10.18632/oncotarget.5651.
|
| 414 |
Potential role of annexin A7 in cancers.Clin Chim Acta. 2013 Aug 23;423:83-9. doi: 10.1016/j.cca.2013.04.018. Epub 2013 Apr 29.
|
| 415 |
Prevalent somatic BRCA1 mutations shape clinically relevant genomic patterns of nasopharyngeal carcinoma in Southeast Europe.Int J Cancer. 2018 Jan 1;142(1):66-80. doi: 10.1002/ijc.31023. Epub 2017 Sep 30.
|
| 416 |
ARF6-mediated endosome recycling reverses lipid accumulation defects in Niemann-Pick Type C disease.PLoS One. 2009;4(4):e5193. doi: 10.1371/journal.pone.0005193. Epub 2009 Apr 14.
|
| 417 |
ARHGAP42 promotes cell migration and invasion involving PI3K/Akt signaling pathway in nasopharyngeal carcinoma.Cancer Med. 2018 Aug;7(8):3862-3874. doi: 10.1002/cam4.1552. Epub 2018 Jun 24.
|
| 418 |
Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma.Cancer Res. 2003 Dec 1;63(23):8293-301.
|
| 419 |
The human ATF1 rs11169571 polymorphism associated with risk of nasopharyngeal carcinoma in Southern Chinese populations.Cancer Med. 2019 Apr;8(4):1893-1898. doi: 10.1002/cam4.2022. Epub 2019 Mar 23.
|
| 420 |
Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro.J Gen Virol. 2008 Nov;89(Pt 11):2833-2842. doi: 10.1099/vir.0.2008/003392-0.
|
| 421 |
Multigene pathway-based analyses identify nasopharyngeal carcinoma risk associations for cumulative adverse effects of TERT-CLPTM1L and DNA double-strand breaks repair.Int J Cancer. 2014 Oct 1;135(7):1634-45. doi: 10.1002/ijc.28802. Epub 2014 Mar 4.
|
| 422 |
BRCC3 acts as a prognostic marker in nasopharyngeal carcinoma patients treated with radiotherapy and mediates radiation resistance in vitro.Radiat Oncol. 2015 May 30;10:123. doi: 10.1186/s13014-015-0427-3.
|
| 423 |
EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC.Oncotarget. 2015 Dec 8;6(39):41766-82. doi: 10.18632/oncotarget.6155.
|
| 424 |
Intracellular expression profile and clinical significance of the CCR9-CCL25 chemokine receptor complex in nasopharyngeal carcinoma.J Laryngol Otol. 2015 Oct;129(10):1013-9. doi: 10.1017/S0022215115002108. Epub 2015 Aug 17.
|
| 425 |
The expression of cyclin G in nasopharyngeal carcinoma and its significance.Clin Exp Med. 2012 Mar;12(1):21-4. doi: 10.1007/s10238-011-0142-9. Epub 2011 Jun 19.
|
| 426 |
Identification of candidate molecular markers of nasopharyngeal carcinoma by microarray analysis of subtracted cDNA libraries constructed by suppression subtractive hybridization.Eur J Cancer Prev. 2008 Nov;17(6):561-71. doi: 10.1097/CEJ.0b013e328305a0e8.
|
| 427 |
CDH4 as a novel putative tumor suppressor gene epigenetically silenced by promoter hypermethylation in nasopharyngeal carcinoma.Cancer Lett. 2011 Oct 1;309(1):54-61. doi: 10.1016/j.canlet.2011.05.016. Epub 2011 Jun 12.
|
| 428 |
Expression of cyclin-dependent kinase 2-associated protein 1 confers an independent prognosticator in nasopharyngeal carcinoma: a cohort study.J Clin Pathol. 2012 Sep;65(9):795-801. doi: 10.1136/jclinpath-2012-200893. Epub 2012 Jul 12.
|
| 429 |
Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis.Acta Biochim Biophys Sin (Shanghai). 2009 May;41(5):414-28. doi: 10.1093/abbs/gmp025.
|
| 430 |
Association of CELF2 polymorphism and the prognosis of nasopharyngeal carcinoma in southern Chinese population.Oncotarget. 2015 Sep 29;6(29):27176-86. doi: 10.18632/oncotarget.4870.
|
| 431 |
Sp1 and Sp3 are involved in the full transcriptional activity of centromere protein H in human nasopharyngeal carcinoma cells.FEBS J. 2012 Aug;279(15):2714-26. doi: 10.1111/j.1742-4658.2012.08654.x. Epub 2012 Jun 25.
|
| 432 |
Identification of a novel methylated gene in nasopharyngeal carcinoma: TTC40.Biomed Res Int. 2014;2014:691742. doi: 10.1155/2014/691742. Epub 2014 Jun 30.
|
| 433 |
Tumor suppressor genes on frequently deleted chromosome 3p in nasopharyngeal carcinoma.Chin J Cancer. 2012 May;31(5):215-22. doi: 10.5732/cjc.011.10364. Epub 2012 Feb 24.
|
| 434 |
Downregulation of hemidesmosomal proteins in nasopharyngeal carcinoma cells.Cancer Lett. 2001 Feb 10;163(1):117-23. doi: 10.1016/s0304-3835(00)00683-2.
|
| 435 |
PGC1/CEBPB/CPT1A axis promotes radiation resistance of nasopharyngeal carcinoma through activating fatty acid oxidation.Cancer Sci. 2019 Jun;110(6):2050-2062. doi: 10.1111/cas.14011. Epub 2019 May 3.
|
| 436 |
Integrated analysis of multiple gene expression profiling datasets revealed novel gene signatures and molecular markers in nasopharyngeal carcinoma.Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):166-75. doi: 10.1158/1055-9965.EPI-11-0593. Epub 2011 Nov 8.
|
| 437 |
Cytochrome b5 reductase 2 is a novel candidate tumor suppressor gene frequently inactivated by promoter hypermethylation in human nasopharyngeal carcinoma.Tumour Biol. 2014 Apr;35(4):3755-63. doi: 10.1007/s13277-013-1497-1. Epub 2013 Dec 12.
|
| 438 |
The microRNA-processing enzymes: Drosha and Dicer can predict prognosis of nasopharyngeal carcinoma.J Cancer Res Clin Oncol. 2012 Jan;138(1):49-56. doi: 10.1007/s00432-011-1058-1. Epub 2011 Sep 28.
|
| 439 |
Selection of reliable reference genes for gene expression study in nasopharyngeal carcinoma.Acta Pharmacol Sin. 2010 Nov;31(11):1487-94. doi: 10.1038/aps.2010.115.
|
| 440 |
Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma.Mol Cancer. 2010 Apr 16;9:78. doi: 10.1186/1476-4598-9-78.
|
| 441 |
Inhibiting ERp29 expression enhances radiosensitivity in human nasopharyngeal carcinoma cell lines.Med Oncol. 2012 Jun;29(2):721-8. doi: 10.1007/s12032-011-9929-5. Epub 2011 Apr 11.
|
| 442 |
Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma.Cancer Res. 2006 Aug 15;66(16):7999-8006. doi: 10.1158/0008-5472.CAN-05-4399.
|
| 443 |
Functional interaction of Ugene and EBV infection mediates tumorigenic effects.Oncogene. 2011 Jun 30;30(26):2921-32. doi: 10.1038/onc.2011.16. Epub 2011 Feb 14.
|
| 444 |
Anti-angiogenic and tumor-suppressive roles of candidate tumor-suppressor gene, Fibulin-2, in nasopharyngeal carcinoma.Oncogene. 2012 Feb 9;31(6):728-38. doi: 10.1038/onc.2011.272. Epub 2011 Jul 11.
|
| 445 |
FEZF2, a novel 3p14 tumor suppressor gene, represses oncogene EZH2 and MDM2 expression and is frequently methylated in nasopharyngeal carcinoma.Carcinogenesis. 2013 Sep;34(9):1984-93. doi: 10.1093/carcin/bgt165. Epub 2013 May 14.
|
| 446 |
Epstein-Barr virus-encoded LMP1 interacts with FGD4 to activate Cdc42 and thereby promote migration of nasopharyngeal carcinoma cells.PLoS Pathog. 2012;8(5):e1002690. doi: 10.1371/journal.ppat.1002690. Epub 2012 May 10.
|
| 447 |
GADD45 induces G2/M arrest in human pharynx and nasopharyngeal carcinoma cells by cucurbitacin E.Sci Rep. 2014 Sep 23;4:6454. doi: 10.1038/srep06454.
|
| 448 |
G(alpha)12-mediated pathway promotes invasiveness of nasopharyngeal carcinoma by modulating actin cytoskeleton reorganization.Cancer Res. 2009 Aug 1;69(15):6122-30. doi: 10.1158/0008-5472.CAN-08-3435. Epub 2009 Jul 14.
|
| 449 |
Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.J Med Virol. 2007 Nov;79(11):1710-21. doi: 10.1002/jmv.20987.
|
| 450 |
Exercise affects platelet-promoted tumor cell adhesion and invasion to endothelium.Eur J Appl Physiol. 2009 Feb;105(3):393-401. doi: 10.1007/s00421-008-0916-2. Epub 2008 Nov 8.
|
| 451 |
A gender-specific association of CNV at 6p21.3 with NPC susceptibility.Hum Mol Genet. 2011 Jul 15;20(14):2889-96. doi: 10.1093/hmg/ddr191. Epub 2011 May 2.
|
| 452 |
Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3.Am J Hum Genet. 2009 Aug;85(2):194-203. doi: 10.1016/j.ajhg.2009.07.007. Epub 2009 Aug 6.
|
| 453 |
Aberrantly hypermethylated Homeobox A2 derepresses metalloproteinase-9 through TBP and promotes invasion in Nasopharyngeal carcinoma.Oncotarget. 2013 Nov;4(11):2154-65. doi: 10.18632/oncotarget.1367.
|
| 454 |
Down-regulation of gp130 in nasopharyngeal carcinoma.Am J Rhinol Allergy. 2009 Jan-Feb;23(1):28-32. doi: 10.2500/ajra.2009.23.3257.
|
| 455 |
Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries.Int J Cancer. 2003 Aug 20;106(2):244-51. doi: 10.1002/ijc.11208.
|
| 456 |
Epigenetic inactivation of inositol polyphosphate 4-phosphatase B (INPP4B), a regulator of PI3K/AKT signaling pathway in EBV-associated nasopharyngeal carcinoma.PLoS One. 2014 Aug 15;9(8):e105163. doi: 10.1371/journal.pone.0105163. eCollection 2014.
|
| 457 |
Targeting of DICE1 tumor suppressor by Epstein-Barr virus-encoded miR-BART3* microRNA in nasopharyngeal carcinoma.Int J Cancer. 2013 Jul;133(1):79-87. doi: 10.1002/ijc.28007. Epub 2013 Feb 12.
|
| 458 |
Kank1 reexpression induced by 5-Aza-2'-deoxycytidine suppresses nasopharyngeal carcinoma cell proliferation and promotes apoptosis.Int J Clin Exp Pathol. 2015 Feb 1;8(2):1658-65. eCollection 2015.
|
| 459 |
Identification Keratin 1 as a cDDP-resistant protein in nasopharyngeal carcinoma cell lines.J Proteomics. 2012 Apr 18;75(8):2352-60. doi: 10.1016/j.jprot.2012.02.003. Epub 2012 Feb 12.
|
| 460 |
Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.J Virol. 2015 Aug;89(15):7612-24. doi: 10.1128/JVI.00958-15. Epub 2015 May 13.
|
| 461 |
LRIG and cancer prognosis.Acta Oncol. 2014 Sep;53(9):1135-42. doi: 10.3109/0284186X.2014.953258. Epub 2014 Sep 2.
|
| 462 |
Expression and clinical significance of LRRC4 in benign and malignant nasopharyngeal diseases.Genet Mol Res. 2015 Dec 9;14(4):16403-9. doi: 10.4238/2015.December.9.9.
|
| 463 |
LTBP-2 confers pleiotropic suppression and promotes dormancy in a growth factor permissive microenvironment in nasopharyngeal carcinoma.Cancer Lett. 2012 Dec 1;325(1):89-98. doi: 10.1016/j.canlet.2012.06.005. Epub 2012 Jun 26.
|
| 464 |
Whole blood transcriptome correlates with treatment response in nasopharyngeal carcinoma.J Exp Clin Cancer Res. 2012 Sep 17;31(1):76. doi: 10.1186/1756-9966-31-76.
|
| 465 |
MACC1 down-regulation inhibits proliferation and tumourigenicity of nasopharyngeal carcinoma cells through Akt/-catenin signaling pathway.PLoS One. 2013;8(4):e60821. doi: 10.1371/journal.pone.0060821. Epub 2013 Apr 3.
|
| 466 |
Inactivation of human MAD2B in nasopharyngeal carcinoma cells leads to chemosensitization to DNA-damaging agents.Cancer Res. 2006 Apr 15;66(8):4357-67. doi: 10.1158/0008-5472.CAN-05-3602.
|
| 467 |
MiR-223 targeting MAFB suppresses proliferation and migration of nasopharyngeal carcinoma cells.BMC Cancer. 2015 Jun 9;15:461. doi: 10.1186/s12885-015-1464-x.
|
| 468 |
Discovery of recurrent structural variants in nasopharyngeal carcinoma.Genome Res. 2014 Feb;24(2):300-9. doi: 10.1101/gr.156224.113. Epub 2013 Nov 8.
|
| 469 |
Candidate pathways and genes for nasopharyngeal carcinoma based on bioinformatics study.Int J Clin Exp Pathol. 2015 Feb 1;8(2):2026-32. eCollection 2015.
|
| 470 |
Module function and two-way clustering analysis of Epstein-Barr virus-related nasopharyngeal cancer.Genet Mol Res. 2014 Mar 17;13(1):1823-31. doi: 10.4238/2014.March.17.10.
|
| 471 |
Dione-thiophene conjugate inhibits proliferation and metastasis of nasopharyngeal carcinoma cells through calcium binding protein-P down-regulation.Eur J Med Chem. 2019 Apr 15;168:199-206. doi: 10.1016/j.ejmech.2019.01.051. Epub 2019 Jan 25.
|
| 472 |
Genome wide detection of oncogene amplifications in nasopharyngeal carcinoma by array based comparative genomic hybridization.Int J Oncol. 2002 Mar;20(3):467-73.
|
| 473 |
Frequent epigenetic inactivation of Myocardin in human nasopharyngeal carcinoma.Head Neck. 2011 Jan;33(1):54-9. doi: 10.1002/hed.21396.
|
| 474 |
Haplotype of gene Nedd4 binding protein 2 associated with sporadic nasopharyngeal carcinoma in the Southern Chinese population.J Transl Med. 2007 Jul 13;5:36. doi: 10.1186/1479-5876-5-36.
|
| 475 |
The Ratio of C-Reactive Protein/Albumin is a Novel Inflammatory Predictor of Overall Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma.Dis Markers. 2017;2017:6570808. doi: 10.1155/2017/6570808. Epub 2017 Jun 6.
|
| 476 |
Neurogenin-2-transduced human neural progenitor cells attenuate neonatal hypoxic-ischemic brain injury.Transl Res. 2017 May;183:121-136.e9. doi: 10.1016/j.trsl.2016.12.010. Epub 2016 Dec 29.
|
| 477 |
Cloning and characterization of the NPCEDRG gene promoter.Mol Cell Biochem. 2011 Jan;346(1-2):1-10. doi: 10.1007/s11010-010-0584-5. Epub 2010 Sep 7.
|
| 478 |
Metastasis-suppressing NID2, an epigenetically-silenced gene, in the pathogenesis of nasopharyngeal carcinoma and esophageal squamous cell carcinoma.Oncotarget. 2016 Nov 29;7(48):78859-78871. doi: 10.18632/oncotarget.12889.
|
| 479 |
The effect of EBV on WIF1, NLK, and APC gene methylation and expression in gastric carcinoma and nasopharyngeal cancer.J Med Virol. 2017 Oct;89(10):1844-1851. doi: 10.1002/jmv.24863. Epub 2017 Jul 6.
|
| 480 |
Changes in the nasopharyngeal carcinoma nuclear proteome induced by the EBNA1 protein of Epstein-Barr virus reveal potential roles for EBNA1 in metastasis and oxidative stress responses.J Virol. 2012 Jan;86(1):382-94. doi: 10.1128/JVI.05648-11. Epub 2011 Oct 19.
|
| 481 |
OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation.PLoS One. 2008 Aug 20;3(8):e2990. doi: 10.1371/journal.pone.0002990.
|
| 482 |
Haptoglobin genotypes in nasopharyngeal carcinoma.Int J Biol Markers. 2009 Jan-Mar;24(1):32-7. doi: 10.5301/jbm.2009.3305.
|
| 483 |
Promoter hypermethylation of high-in-normal 1 gene in primary nasopharyngeal carcinoma.Clin Cancer Res. 2003 Aug 1;9(8):3042-6.
|
| 484 |
Protocadherin8 is a functional tumor suppressor frequently inactivated by promoter methylation in nasopharyngeal carcinoma.Eur J Cancer Prev. 2012 Nov;21(6):569-75. doi: 10.1097/CEJ.0b013e328350b097.
|
| 485 |
Promoter hypermethylation of CCNA1, RARRES1, and HRASLS3 in nasopharyngeal carcinoma.Oral Oncol. 2008 Apr;44(4):400-6. doi: 10.1016/j.oraloncology.2007.05.008. Epub 2007 Aug 3.
|
| 486 |
MicroRNA-1 induces apoptosis by targeting prothymosin alpha in nasopharyngeal carcinoma cells.J Biomed Sci. 2011 Nov 7;18(1):80. doi: 10.1186/1423-0127-18-80.
|
| 487 |
Prostate Tumor Overexpressed 1 (PTOV1) Is a Novel Prognostic Marker for Nasopharyngeal Carcinoma Progression and Poor Survival Outcomes.PLoS One. 2015 Aug 25;10(8):e0136448. doi: 10.1371/journal.pone.0136448. eCollection 2015.
|
| 488 |
PTPRG suppresses tumor growth and invasion via inhibition of Akt signaling in nasopharyngeal carcinoma.Oncotarget. 2015 May 30;6(15):13434-47. doi: 10.18632/oncotarget.3876.
|
| 489 |
Aberrant methylation of RASSF4/AD037 in nasopharyngeal carcinoma.Oncol Rep. 2004 Oct;12(4):781-7.
|
| 490 |
Downregulation of Ras association domain family member 6 (RASSF6) underlies the treatment resistance of highly metastatic nasopharyngeal carcinoma cells.PLoS One. 2014 Jul 16;9(7):e100843. doi: 10.1371/journal.pone.0100843. eCollection 2014.
|
| 491 |
RNA binding motif protein 3 (RBM3) drives radioresistance in nasopharyngeal carcinoma by reducing apoptosis via the PI3K/AKT/Bcl-2 signaling pathway.Am J Transl Res. 2018 Dec 15;10(12):4130-4140. eCollection 2018.
|
| 492 |
Epigenetic silencing of cellular retinol-binding proteins in nasopharyngeal carcinoma.Neoplasia. 2005 Jan;7(1):67-74. doi: 10.1593/neo.04370.
|
| 493 |
Differential expression of a subset of ribosomal protein genes in cell lines derived from human nasopharyngeal epithelium.J Hum Genet. 2010 Feb;55(2):118-20. doi: 10.1038/jhg.2009.124. Epub 2009 Nov 20.
|
| 494 |
Promoter hypermethylation of Ras-related GTPase gene RRAD inactivates a tumor suppressor function in nasopharyngeal carcinoma.Cancer Lett. 2012 Oct 28;323(2):147-54. doi: 10.1016/j.canlet.2012.03.042. Epub 2012 Apr 6.
|
| 495 |
Expression of seven-in-absentia homologue 1 and hypoxia-inducible factor 1 alpha: novel prognostic factors of nasopharyngeal carcinoma.Cancer Lett. 2013 Apr 30;331(1):52-7. doi: 10.1016/j.canlet.2012.12.002. Epub 2012 Dec 8.
|
| 496 |
Anticancer activity of recombinant Siva1 protein in human nasopharyngeal carcinoma cell line CNE-2.Cancer Biomark. 2015;15(6):833-41. doi: 10.3233/CBM-150527.
|
| 497 |
The relationship between secretory leukocyte protease inhibitor expression and Epstein-Barr virus status among patients with nasopharyngeal carcinoma.Anticancer Res. 2012 Apr;32(4):1299-307.
|
| 498 |
MiR-142-3p Suppresses SOCS6 Expression and Promotes Cell Proliferation in Nasopharyngeal Carcinoma.Cell Physiol Biochem. 2015;36(5):1743-52. doi: 10.1159/000430147.
|
| 499 |
SOX1 down-regulates -catenin and reverses malignant phenotype in nasopharyngeal carcinoma.Mol Cancer. 2014 Nov 26;13:257. doi: 10.1186/1476-4598-13-257.
|
| 500 |
Reversing effect of sorcin in the drug resistance of human nasopharyngeal carcinoma.Anat Rec (Hoboken). 2014 Feb;297(2):215-21. doi: 10.1002/ar.22832. Epub 2013 Dec 24.
|
| 501 |
Silencing of long noncoding RNA SRRM2-AS exerts suppressive effects on angiogenesis in nasopharyngeal carcinoma via activating MYLK-mediated cGMP-PKG signaling pathway.J Cell Physiol. 2020 Nov;235(11):7757-7768. doi: 10.1002/jcp.29382. Epub 2019 Nov 19.
|
| 502 |
Functional analysis of the nasopharyngeal carcinoma primary tumorassociated gene interaction network.Mol Med Rep. 2015 Oct;12(4):4975-80. doi: 10.3892/mmr.2015.4090. Epub 2015 Jul 20.
|
| 503 |
Sequence variants in toll-like receptor 10 are associated with nasopharyngeal carcinoma risk.Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):862-6. doi: 10.1158/1055-9965.EPI-05-0874.
|
| 504 |
Correlation of p21 gene codon 31 polymorphism and TNF-alpha gene polymorphism with nasopharyngeal carcinoma.J Clin Lab Anal. 2002;16(3):146-50. doi: 10.1002/jcla.10032.
|
| 505 |
Expression of tumor necrosis factor receptor-associated factor 1 in nasopharyngeal carcinoma: possible upregulation by Epstein-Barr virus latent membrane protein 1.Int J Cancer. 2004 Nov 1;112(2):265-72. doi: 10.1002/ijc.20367.
|
| 506 |
LPLUNC1 stabilises PHB1 by counteracting TRIM21-mediated ubiquitination to inhibit NF-B activity in nasopharyngeal carcinoma.Oncogene. 2019 Jun;38(25):5062-5075. doi: 10.1038/s41388-019-0778-6. Epub 2019 Mar 18.
|
| 507 |
Characterization of TRIP6-dependent nasopharyngeal cancer cell migration.Tumour Biol. 2013 Aug;34(4):2329-35. doi: 10.1007/s13277-013-0780-5. Epub 2013 Apr 11.
|
| 508 |
ADAMTS9 is Silenced by Epigenetic Disruption in Colorectal Cancer and Inhibits Cell Growth and Metastasis by Regulating Akt/p53 Signaling.Cell Physiol Biochem. 2017;44(4):1370-1380. doi: 10.1159/000485534. Epub 2017 Nov 30.
|
| 509 |
Reduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinoma.PLoS One. 2017 Feb 10;12(2):e0171985. doi: 10.1371/journal.pone.0171985. eCollection 2017.
|
| 510 |
miR-346 promotes migration and invasion of nasopharyngeal carcinoma cells via targeting BRMS1.J Biochem Mol Toxicol. 2016 Dec;30(12):602-607. doi: 10.1002/jbt.21827. Epub 2016 Aug 8.
|
| 511 |
Folic acid inhibits nasopharyngeal cancer cell proliferation and invasion via activation of FR/ERK1/2/TSLC1 pathway. Biosci Rep. 2017 Dec 5;37(6):BSR20170772. doi: 10.1042/BSR20170772. Print 2017 Dec 22.
|
| 512 |
Capn4 is induced by and required for Epstein-Barr virus latent membrane protein 1 promotion of nasopharyngeal carcinoma metastasis through ERK/AP-1 signaling.Cancer Sci. 2020 Jan;111(1):72-83. doi: 10.1111/cas.14227. Epub 2019 Nov 25.
|
| 513 |
Anti-interleukin-10 antibodies in patients with chronic active Epstein-Barr virus infection.J Infect Dis. 1997 Dec;176(6):1454-61. doi: 10.1086/514141.
|
| 514 |
Transmembrane Domains Mediate Intra- and Extracellular Trafficking of Epstein-Barr Virus Latent Membrane Protein 1.J Virol. 2018 Aug 16;92(17):e00280-18. doi: 10.1128/JVI.00280-18. Print 2018 Sep 1.
|
| 515 |
KAI1 overexpression promotes apoptosis and inhibits proliferation, cell cycle, migration, and invasion in nasopharyngeal carcinoma cells.Am J Otolaryngol. 2017 Sep-Oct;38(5):511-517. doi: 10.1016/j.amjoto.2016.09.011. Epub 2016 Sep 28.
|
| 516 |
Downregulated CDK10 expression in gastric cancer: Association with tumor progression and poor prognosis.Mol Med Rep. 2018 May;17(5):6812-6818. doi: 10.3892/mmr.2018.8662. Epub 2018 Mar 1.
|
| 517 |
PARP1 is overexpressed in nasopharyngeal carcinoma and its inhibition enhances radiotherapy.Mol Cancer Ther. 2013 Nov;12(11):2517-28. doi: 10.1158/1535-7163.MCT-13-0010. Epub 2013 Aug 26.
|
| 518 |
Tobacco consumption and genetic susceptibility to nasopharyngeal carcinoma (NPC) in Thailand.Cancer Causes Control. 2012 Dec;23(12):1995-2002. doi: 10.1007/s10552-012-0077-9. Epub 2012 Oct 21.
|
| 519 |
Increased expression of Cks1 protein is associated with lymph node metastasis and poor prognosis in nasopharyngeal carcinoma.Diagn Pathol. 2017 Jan 7;12(1):2. doi: 10.1186/s13000-016-0589-9.
|
| 520 |
Leukocyte telomere length associates with nasopharyngeal carcinoma risk and survival in Hong Kong Chinese.Int J Cancer. 2018 Nov 1;143(9):2289-2298. doi: 10.1002/ijc.31617. Epub 2018 Aug 7.
|
| 521 |
Improved Radiotherapy Sensitivity of Nasopharyngeal Carcinoma Cells by miR-29-3p Targeting COL1A1 3'-UTR.Med Sci Monit. 2019 Apr 29;25:3161-3169. doi: 10.12659/MSM.915624.
|
| 522 |
Correlation between COX-2 gene polymorphism and susceptibility to nasopharyngeal carcinoma.Eur Rev Med Pharmacol Sci. 2019 Jul;23(13):5770-5778. doi: 10.26355/eurrev_201907_18315.
|
| 523 |
Anti-angiogenic pathway associations of the 3p21.3 mapped BLU gene in nasopharyngeal carcinoma.Oncogene. 2015 Aug 6;34(32):4219-28. doi: 10.1038/onc.2014.353. Epub 2014 Oct 27.
|
| 524 |
Identification of candidate nasopharyngeal carcinoma serum biomarkers by cancer cell secretome and tissue transcriptome analysis: potential usage of cystatin A for predicting nodal stage and poor prognosis.Proteomics. 2010 Jul;10(14):2644-60. doi: 10.1002/pmic.200900620.
|
| 525 |
MicroRNA-93 promotes cell growth and invasion in nasopharyngeal carcinoma by targeting disabled homolog-2.Cancer Lett. 2015 Jul 28;363(2):146-55. doi: 10.1016/j.canlet.2015.04.006. Epub 2015 Apr 16.
|
| 526 |
Inactivation of RASSF1A, RARbeta2 and DAP-kinase by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma.Cancer Biol Ther. 2009 Mar;8(5):444-51. doi: 10.4161/cbt.8.5.7686. Epub 2009 Mar 21.
|
| 527 |
Tumor suppressor dual-specificity phosphatase 6 (DUSP6) impairs cell invasion and epithelial-mesenchymal transition (EMT)-associated phenotype.Int J Cancer. 2012 Jan 1;130(1):83-95. doi: 10.1002/ijc.25970. Epub 2011 Apr 20.
|
| 528 |
Downregulated ECRG4 is correlated with lymph node metastasis and predicts poor outcome for nasopharyngeal carcinoma patients.Clin Transl Oncol. 2017 Jan;19(1):84-90. doi: 10.1007/s12094-016-1507-z. Epub 2016 Apr 27.
|
| 529 |
EMP2 re-expression inhibits growth and enhances radiosensitivity in nasopharyngeal carcinoma.Tumour Biol. 2017 Mar;39(3):1010428317695972. doi: 10.1177/1010428317695972.
|
| 530 |
Is excision repair cross-complementation Group1 expression a biological marker in nasopharynx carcinoma?.J Cancer Res Ther. 2019 Jul-Sep;15(3):550-555. doi: 10.4103/0973-1482.206865.
|
| 531 |
Snail promotes metastasis of nasopharyngeal carcinoma partly by down-regulating TEL2.Cancer Commun (Lond). 2018 Sep 25;38(1):58. doi: 10.1186/s40880-018-0328-6.
|
| 532 |
Oncogenic fibulin-5 promotes nasopharyngeal carcinoma cell metastasis through the FLJ10540/AKT pathway and correlates with poor prognosis.PLoS One. 2013 Dec 27;8(12):e84218. doi: 10.1371/journal.pone.0084218. eCollection 2013.
|
| 533 |
An Oncogenic Role for Four-Jointed Box 1 (FJX1) in Nasopharyngeal Carcinoma.Dis Markers. 2019 May 19;2019:3857853. doi: 10.1155/2019/3857853. eCollection 2019.
|
| 534 |
Prognostic value of flotillins (flotillin-1 and flotillin-2) in human cancers: A meta-analysis.Clin Chim Acta. 2018 Jun;481:90-98. doi: 10.1016/j.cca.2018.02.036. Epub 2018 Feb 28.
|
| 535 |
The role of MALAT1/miR-1/slug axis on radioresistance in nasopharyngeal carcinoma.Tumour Biol. 2016 Mar;37(3):4025-33. doi: 10.1007/s13277-015-4227-z. Epub 2015 Oct 20.
|
| 536 |
Follistatin-Like Protein-1 Upregulates Dendritic Cell-Based Immunity in Patients with Nasopharyngeal Carcinoma.J Interferon Cytokine Res. 2017 Nov;37(11):494-502. doi: 10.1089/jir.2017.0064.
|
| 537 |
Detection of nasopharyngeal carcinoma susceptibility with single nucleotide polymorphism analysis using next-generation sequencing technology.Oncotarget. 2017 Apr 13;8(32):52708-52723. doi: 10.18632/oncotarget.17085. eCollection 2017 Aug 8.
|
| 538 |
Role of the RARRES1 gene in nasopharyngeal carcinoma.Cancer Genet Cytogenet. 2009 Oct;194(1):58-64. doi: 10.1016/j.cancergencyto.2009.06.005.
|
| 539 |
Fine-mapping of HLA class I and class II genes identified two independent novel variants associated with nasopharyngeal carcinoma susceptibility.Cancer Med. 2018 Dec;7(12):6308-6316. doi: 10.1002/cam4.1838. Epub 2018 Oct 30.
|
| 540 |
Are HLA-E*0103 alleles predictive markers for nasopharyngeal cancer risk?.Pathol Res Pract. 2016 Apr;212(4):345-9. doi: 10.1016/j.prp.2016.01.010. Epub 2016 Feb 2.
|
| 541 |
MicroRNA-185 inhibits cell proliferation while promoting apoptosis and autophagy through negative regulation of TGF-1/mTOR axis and HOXC6 in nasopharyngeal carcinoma.Cancer Biomark. 2018;23(1):107-123. doi: 10.3233/CBM-181459.
|
| 542 |
N,N'-dinitrosopiperazine--mediated heat-shock protein 70-2 expression is involved in metastasis of nasopharyngeal carcinoma.PLoS One. 2013 May 7;8(5):e62908. doi: 10.1371/journal.pone.0062908. Print 2013.
|
| 543 |
Interferon-alpha and p53 alleles involved in nasopharyngeal carcinoma.Carcinogenesis. 1997 Apr;18(4):645-7. doi: 10.1093/carcin/18.4.645.
|
| 544 |
Expression of interferon regulatory factor 7 correlates with the expression of Epstein-Barr Virus latent membrane protein 1 and cervical lymph node metastasis in nasopharyngeal cancer.Pathol Int. 2017 Sep;67(9):461-466. doi: 10.1111/pin.12561. Epub 2017 Jul 16.
|
| 545 |
Effects of KIF2A on the prognosis of nasopharyngeal carcinoma and nasopharyngeal carcinoma cells.Oncol Lett. 2019 Sep;18(3):2718-2723. doi: 10.3892/ol.2019.10597. Epub 2019 Jul 9.
|
| 546 |
Overexpression of the Oncogenic Variant (KLF6-SV1) in Young NPC Patients and Correlation with Lack of E-Cadherin.Anal Cell Pathol (Amst). 2018 Apr 19;2018:9654067. doi: 10.1155/2018/9654067. eCollection 2018.
|
| 547 |
Mitotic arrest deficient 2 expression induces chemosensitization to a DNA-damaging agent, cisplatin, in nasopharyngeal carcinoma cells.Cancer Res. 2005 Feb 15;65(4):1450-8. doi: 10.1158/0008-5472.CAN-04-0567.
|
| 548 |
Cinobufotalin powerfully reversed EBV-miR-BART22-induced cisplatin resistance via stimulating MAP2K4 to antagonize non-muscle myosin heavy chain IIA/glycogen synthase 3/-catenin signaling pathway.EBioMedicine. 2019 Oct;48:386-404. doi: 10.1016/j.ebiom.2019.08.040. Epub 2019 Oct 5.
|
| 549 |
FBW7 increases drug sensitivity to cisplatin in human nasopharyngeal carcinoma by downregulating the expression of multidrug resistance-associated protein.Tumour Biol. 2015 Jun;36(6):4197-202. doi: 10.1007/s13277-015-3056-4. Epub 2015 Jan 14.
|
| 550 |
Loss of NFBD1/MDC1 disrupts homologous recombination repair and sensitizes nasopharyngeal carcinoma cells to PARP inhibitors.J Biomed Sci. 2019 Feb 4;26(1):14. doi: 10.1186/s12929-019-0507-z.
|
| 551 |
Chemical compound cinobufotalin potently induces FOXO1-stimulated cisplatin sensitivity by antagonizing its binding partner MYH9.Signal Transduct Target Ther. 2019 Nov 18;4:48. doi: 10.1038/s41392-019-0084-3. eCollection 2019.
|
| 552 |
Prognostic significance of DNA flow cytometric analysis in patients with nasopharyngeal carcinoma.Cancer. 1998 Dec 1;83(11):2284-92.
|
| 553 |
Methylation of nucleolar and coiled-body phosphoprotein1 is associated with the mechanism of tumorigenesis in hepatocellular carcinoma.Oncol Rep. 2013 Nov;30(5):2220-8. doi: 10.3892/or.2013.2676. Epub 2013 Aug 20.
|
| 554 |
The characteristics and biological significance of NPC2: Mutation and disease.Mutat Res Rev Mutat Res. 2019 Oct-Dec;782:108284. doi: 10.1016/j.mrrev.2019.108284. Epub 2019 Jul 8.
|
| 555 |
miR-504 mediated down-regulation of nuclear respiratory factor 1 leads to radio-resistance in nasopharyngeal carcinoma.Oncotarget. 2015 Jun 30;6(18):15995-6018. doi: 10.18632/oncotarget.4138.
|
| 556 |
OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma.Theranostics. 2018 Mar 8;8(8):2202-2216. doi: 10.7150/thno.24003. eCollection 2018.
|
| 557 |
High-resolution melting analysis of PCDH10 methylation levels in gastric, colorectal and pancreatic cancers.Neoplasma. 2010;57(3):247-52. doi: 10.4149/neo_2010_03_247.
|
| 558 |
MircoRNA-629 promotes proliferation, invasion and migration of nasopharyngeal carcinoma through targeting PDCD4.Eur Rev Med Pharmacol Sci. 2019 Jan;23(1):207-216. doi: 10.26355/eurrev_201901_16766.
|
| 559 |
Differential expression of osteoblast-specific factor 2 and polymeric immunoglobulin receptor genes in nasopharyngeal carcinoma.Head Neck. 2005 Oct;27(10):873-82. doi: 10.1002/hed.20253.
|
| 560 |
Comprehensive pathway-based association study of DNA repair gene variants and the risk of nasopharyngeal carcinoma.Cancer Res. 2011 Apr 15;71(8):3000-8. doi: 10.1158/0008-5472.CAN-10-0469. Epub 2011 Mar 2.
|
| 561 |
Mutation screening analysis of the retinoblastoma related gene RB2/p130 in sporadic ovarian cancer and head and neck squamous cell cancer.Mol Pathol. 2002 Jun;55(3):153-5. doi: 10.1136/mp.55.3.153.
|
| 562 |
RBMS3 is a tumor suppressor gene that acts as a favorable prognostic marker in lung squamous cell carcinoma.Med Oncol. 2015 Feb;32(2):459. doi: 10.1007/s12032-014-0459-9. Epub 2015 Jan 15.
|
| 563 |
Inflammation and cancer.Environ Health Prev Med. 2018 Oct 20;23(1):50. doi: 10.1186/s12199-018-0740-1.
|
| 564 |
Quantitation of DNA methylation in Epstein-Barr virus-associated nasopharyngeal carcinoma by bisulfite amplicon sequencing.BMC Cancer. 2017 Jul 17;17(1):489. doi: 10.1186/s12885-017-3482-3.
|
| 565 |
Radiomics Analysis of PET and CT Components of PET/CT Imaging Integrated with Clinical Parameters: Application to Prognosis for Nasopharyngeal Carcinoma.Mol Imaging Biol. 2019 Oct;21(5):954-964. doi: 10.1007/s11307-018-01304-3.
|
| 566 |
Identification of genes involved in radioresistance of nasopharyngeal carcinoma by integrating gene ontology and protein-protein interaction networks.Int J Oncol. 2012 Jan;40(1):85-92. doi: 10.3892/ijo.2011.1172. Epub 2011 Aug 19.
|
| 567 |
F-127-PEI co-delivering docetaxel and TFPI-2 plasmid for nasopharyngeal cancer therapy.Mater Sci Eng C Mater Biol Appl. 2016 Apr 1;61:269-77. doi: 10.1016/j.msec.2015.12.049. Epub 2015 Dec 24.
|
| 568 |
Secreted TGF-beta-induced protein promotes aggressive progression in bladder cancer cells.Cancer Manag Res. 2019 Jul 25;11:6995-7006. doi: 10.2147/CMAR.S208984. eCollection 2019.
|
| 569 |
MicroRNA-139-5p affects cisplatin sensitivity in human nasopharyngeal carcinoma cells by regulating the epithelial-to-mesenchymal transition.Gene. 2018 Apr 30;652:48-58. doi: 10.1016/j.gene.2018.02.003. Epub 2018 Feb 8.
|
| 570 |
Expression and purification of a rapidly degraded protein, TMEM8B-a, in mammalian cell line.Protein Expr Purif. 2018 Nov;151:38-45. doi: 10.1016/j.pep.2018.06.002. Epub 2018 Jun 8.
|
| 571 |
NF-B-mediated transcriptional upregulation of TNFAIP2 by the Epstein-Barr virus oncoprotein, LMP1, promotes cell motility in nasopharyngeal carcinoma.Oncogene. 2014 Jul 10;33(28):3648-59. doi: 10.1038/onc.2013.345. Epub 2013 Aug 26.
|
| 572 |
TNFRSF19 Inhibits TGF Signaling through Interaction with TGF Receptor Type I to Promote Tumorigenesis.Cancer Res. 2018 Jul 1;78(13):3469-3483. doi: 10.1158/0008-5472.CAN-17-3205. Epub 2018 May 7.
|
| 573 |
MicroRNA?22 acts as tumor suppressor by targeting TRIM29 and blocking the activity of PI3K/AKT signaling in nasopharyngeal carcinoma invitro.Mol Med Rep. 2018 Jun;17(6):8244-8252. doi: 10.3892/mmr.2018.8894. Epub 2018 Apr 19.
|
|
|
|
|
|
|
